Flexible double-arm phenylboronic acid, its synthesis and enrichment materials, preparation and application
By preparing intelligent responsive hydrogel materials, the problems of high cost and damage to CTC integrity in existing CTC detection platforms have been solved, achieving efficient CTC enrichment and non-destructive release, thus improving the effectiveness of cancer diagnosis and treatment.
Patent Information
- Application Number
- CN202510595611.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-05-09
- Publication Date
- 2026-11-10
AI Technical Summary
Existing CTC detection platforms are costly, complex to operate, and destroy the integrity of CTCs, making it difficult to efficiently capture and accurately analyze circulating tumor cells, thus affecting early cancer diagnosis and treatment.
A smart responsive hydrogel material was prepared by copolymerizing multi-hydrogen bonded artificial antibody functional monomers and combining them with cell micromorphology design to create a hydrogel framework with highly selective capture and non-destructive release capabilities for the enrichment and identification of CTCs.
It achieves efficient enrichment and non-destructive release of CTCs, improving the accuracy and reliability of cancer diagnosis, and is applicable to cancer diagnosis and treatment.
Smart Images

Figure CN123062467A_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of biomedicine, specifically to the synthesis of flexible double-arm phenylboronic acid, the preparation method of flexible double-arm phenylboronic acid glycopeptide-enriched filler, the preparation method of flexible double-arm phenylboronic acid hydrogel and cell-imprinted microstructure, the practical application of glycopeptide-enriched filler, and the clinical use of intelligent responsive hydrogel cancer diagnostic biomaterials. Background Technology
[0002] With the continued rise in cancer patients worldwide, early diagnosis and precision treatment have become key strategies for reducing cancer mortality. Liver cancer, as one of the leading causes of cancer-related deaths globally, faces significant challenges in early diagnosis due to the difficulty in detecting and identifying the disease. Circulating tumor cells (CTCs), a rare cell population that detaches from the primary tumor and enters the peripheral blood circulation, are widely recognized as important biomarkers for early cancer diagnosis, efficacy evaluation, and prognostic monitoring due to their non-invasive nature, real-time dynamic monitoring capabilities, and unique advantages in preserving complete tumor biological information. However, the extreme rarity (1-2 cells / mL of blood), high heterogeneity, interference from the complex blood microenvironment, and invasiveness of CTCs pose serious challenges to their efficient capture and accurate analysis. Existing commercial CTC detection platforms (such as the CellSearch system) suffer from inherent drawbacks such as high cost, complex operation, and damage to CTC integrity, severely limiting their application value in precision medicine. To address the aforementioned bottlenecks, this invention develops a biocompatible gel framework with significant anti-adhesion and anti-swelling properties based on cellular micromorphology design. Furthermore, by copolymerizing multi-hydrogen-bonded artificial antibody functional monomers, smart responsive polymer surface hydrogels with varying degrees of polymerization, enrichment capabilities, and ease of processing are prepared. These smart responsive hydrogels have demonstrated excellent performance in the separation and enrichment of CTCs, primarily exhibiting highly selective capture and non-destructive release. Therefore, they hold promise for widespread application in CTC enrichment and identification, and consequently, in clinical cancer diagnosis and treatment. Summary of the Invention
[0003] The purpose of this invention is to provide a method for preparing intelligent responsive biomaterials for cancer diagnosis, which possess the ability to efficiently enrich and release without damage. By preparing a class of functional monomers with selective recognition capabilities of multiple hydrogen bonds and using a copolymerization reaction initiated by potassium persulfate (KPS), cellular microstructures are incorporated into a gel framework with good biocompatibility, non-swelling, anti-adhesion, and plasticity, thus preparing biomaterials for cancer diagnosis and treatment.
[0004] The objective of this invention is achieved through the following approach:
[0005] First, the purpose of this invention is to provide a class of smart responsive polymer cancer biodiagnostic materials, having the following: P1 functionalized silica sphere filler enriched with glycopeptides, P2, P3 and P4 hydrogel polymer network backbone, and P5, P6, P7 and P8 hydrogel functional polymers targeting CTCs.
[0006] The specific description is as follows: The functionalized silica ball filler P1 is synthesized by surface grafting of a silane coupling agent followed by a sulfur bond chemical reaction. Specifically, 3-mercaptopropyltrimethoxysilane is grafted onto the surface of silica microspheres to expose thiol groups. Subsequently, DPBA is introduced through a sulfur bond chemical reaction between the thiol and alkenyl groups in DPBA to obtain DPBA@SiO2.
[0007] The hydrogel polymer P2 is composed of a network backbone (polyethylene glycol methacrylate, PEGMA), where n1 = 1 to 10; the network backbone P4 (polyethylene glycol dimethacrylate, PEGDMA) and polyethylene glycol methacrylate have the same mass, and n2 = 1 to 15; polymer P3 is composed of a network backbone PEGMA and a crosslinking agent PEGDMA, where x and 1-x are the molar percentages of the network backbone and the crosslinking agent, and 1-x = 0.01 to 0.5.
[0008] The cancer biodiagnostic materials contain hydrogel functional polymers P5, P6, P7, or P8 that target CTCs, each composed of a network backbone P4 and functional monomers (P5: methacryloyl-3-aminophenylboronic acid; P6: flexible two-arm phenylboronic acid; P7: rigid two-arm phenylboronic acid; P8: flexible two-arm phenylboronic acid and acryloyl-isothiocyanate fluorescein), where y and 1-y are the molar percentages of P4 and the functional monomers, and y = 0.01–0.5.
[0009] The molecular structures of P1, P2, P3, P4, P5, P6, P7, and P8 are shown below (the polymerization process is random copolymerization):
[0010]
[0011] Secondly, the preparation method of the intelligent responsive hydrogel of the present invention: using the atom transfer radical polymerization reaction mechanism, through potassium persulfate (KPS) initiation, the functional monomers with high specificity, affinity and multi-hydrogen bond selective recognition ability of CTC are randomly copolymerized onto the surface of the P4 gel network backbone with good biocompatibility, non-swelling, anti-adhesion and plasticity, to obtain a hydrogel cancer diagnostic biomaterial carrying functional groups.
[0012] Finally, the preparation method of the intelligent responsive hydrogel of the present invention is as follows: using CTC as a template, the cell micromorphology is introduced into the surface of the hydrogel polymer material carrying functional groups to form cell imprints, thereby obtaining a dual intelligent responsive hydrogel cancer diagnostic biomaterial carrying functional groups and molecular imprints.
[0013] The intelligent responsive hydrogel biomaterial of this invention can be applied in the fields of CTC enrichment and non-destructive release in cancer diagnosis and treatment to participate in downstream molecular biological analysis of diseases, as well as assessing cancer progression. Attached Figure Description
[0014] Figure 1 Identification of recognition sites for hepatocellular carcinoma (HCC) tumor cells using P1 packing material, including: (a) a flowchart of proteomics analysis of proteins on the cell membrane of HCC tumor cells using P1 packing material as a glycopeptide enrichment material; (b) the distribution ratio of glycoproteins identified by mass spectrometry analysis, and the different glycan structures in the glycoproteins; (c) the UniProt ID of the glycoproteins identified by mass spectrometry analysis; (d) the protein and RNA expression levels of glycoproteins identified in HCC from the Human Protein Atlas Database; protein expression levels are divided into high (A), medium (B), low (C), and very low (D); RNA expression is represented as + (>50 FPKM) and – (<50 FPKM); (e) the three-dimensional protein structures of complement factor B (CFB) and ceruloplasmin (CP), highlighting the modification of bibranched sialic acid glycopeptides at Asn107 and Asn358 sites, which can be used as potential binding sites for P1 packing material to tumor cells.
[0015] Figure 2 The P6+ intelligent responsive hydrogel was used for clinical liver cancer detection, and the combined use of two indicators improved diagnostic efficiency. The results included: (a) the number of CTCs captured by the P6+ hydrogel, divided into cancer, cirrhosis, and normal groups; each measurement used a 5mL blood sample; (b) a trend distribution plot of AFP, where the black dashed line represents the cutoff value for identifying cancer cases among volunteers; (c) a receiver operating characteristic (ROC) curve based on a random forest model depicting the combination of AFP, CTCs, and AFP+CTCs; and (d) 100mm... 2 1 mL of blood and P6+ hydrogel (100 mm) within the area 2 Fluorescence microscopy image of white blood cells in 100 μm; scale bar: 100 μm.
[0016] Figure 3The fluorescent probe competitive binding experiment verified the binding ability of the functional monomer to sialic acid, including: (a, b) the fluorescence spectra of HBQ (a, 50 μM) after adding different equivalents of DPBA, and the fluorescence spectra of HBQ-DPBA mixture (b, 50 μM) after adding different equivalents of Neu5Ac (N-acetylneuraminic acid); (c, d) the changes in fluorescence intensity (at 506 nm) of HBQ after adding different equivalents of PBA (black), DPBH (blue), or DPBA (red) (c), and the changes in fluorescence intensity (at 506 nm) of HBQ-PBA, HBQ-DPBH, or HBQ-DPBA after adding different equivalents of Neu5Ac (d); the excitation wavelength (λ) ex 370 nm, slit width: 3.0 / 5.0 nm. A mixture of H2O and DMSO (4:1, v / v) was used as the solvent at 20 °C.
[0017] Figure 4 1. Biomembrane interference experiments were used to verify the binding ability of functional monomers to bibranched sialylated glycans. Among them: (a, c) the binding and dissociation kinetics of DPBA at different concentrations (3, 6, 12, 25 and 50 μM) on the sensor surfaces modified with Neu5Ac-α-Gal-β-Glc (a) and bibranched sialylated glycans (b), recorded by BLI tests at 20 °C; (b) BLI fitting curves of the interaction between DPBA and Neu5Ac-α-Gal-β-Glc; (d) BLI fitting curves of the interaction between PBA, DPBH or DPBA and bibranched sialylated glycans.
[0018] Figure 5 Characterization of P1 packing, including: (a) thermogravimetric analysis of P1 packing; (b) scanning electron microscopy image of the surface of P1 packing; scale bar: 10 μm.
[0019] Figure 6 The specific enrichment of standard sialic acid glycoprotein fetoglobulin sialic acid glycopeptides by P1 packing material, wherein: (a) a flowchart of the strategy for enriching sialic acid glycopeptides using a micro SPE column filled with P1 packing material; (b) mass spectrometry of glycopeptides enriched from fetoglobulin trypsin digest using P1 packing material; the glycopeptides are labeled with asterisks or their corresponding glycan structures: ■: N-acetylglucosamine; ●: mannose; Galactose; ◆: Sialic acid.
[0020] Figure 7The anti-swelling properties of P3, P4, and P6 hydrogels, including: (a, b) the time dependence of swelling rate curves (a, n=6) and free water distribution curve (b) of P3, P4, and P6 hydrogels treated with PBS; (c) a schematic diagram illustrating the swelling of the conventional polymer network in water and the anti-swelling properties caused by PEGDMA chemical crosslinking; (df) scanning electron microscopy images of the surfaces of P3, P4, and P6 hydrogels after soaking in PBS for 50 h; the SEM samples were prepared by dehydration and drying of the hydrogels; scale bar: 100 μm.
[0021] Figure 8 In-situ temperature-varying infrared spectra of P2, P4, and P6 hydrogels, where: (a) schematic diagram of hydrogen bonding interactions between the hydrogel and water molecules at different temperatures. (bg) magnified in-situ Fourier transform infrared (FT-IR) spectra of P2 (b, e), P4 (c, f), and P6 (d, g) hydrogels treated at different temperatures. FT-IR spectral data have been normalized and can be used to compare peak height changes. Dashed arrows indicate temperature increases and peak shifts.
[0022] Figure 9 Preparation and characterization of the microstructure of P6+ and P8+ hydrogel cell imprints, including: (a) scanning electron microscopy image of the P6+ hydrogel surface; the indented areas correspond to cell imprints; scale bar: 100 μm; (b) three-dimensional image of the P6+ hydrogel obtained by atomic force microscopy; scale bar: 5 μm; (c) 3D visualization image of target cells falling into the imprinted area of the P8+ hydrogel observed by Zeiss laser confocal microscopy; scale bar: 12 μm; (d) 3D reconstructed CLSM image of the imprinted microstructure in the P8+ hydrogel; scale bar: 10 μm.
[0023] Figure 10 Blood compatibility of P4 and P6 hydrogels, including: (a) whole blood clotting time of human blood samples incubated with P4 and P6 hydrogels at a concentration of 20 mg / mL (***P = 0.0002 and *P = 0.0186); the blank group consisted of blood samples; (b) hemolysis rate of erythrocytes after incubation with P4 and P6 hydrogels at a concentration of 20 mg / mL for 2.5 hours; (+): positive control, (-): negative control; data are expressed as mean ± SD (n = 6); one-way ANOVA followed by Tukey post-hoc test (a); *P < 0.05 and ***P < 0.001.
[0024] Figure 11 The capture efficiency, release activity, and cell adaptation of P6+ hydrogel to SMMC-7721 cells were evaluated, including: (a) the effect of P6+ hydrogel on different concentrations (10, 10... 2 10 3 104 and 10 5 Capture efficiency of SMMC-7721 cells (cells / mL); (a) One-way ANOVA followed by Tukey post-hoc test; P>0.05 (ns); (b) Cell viability of SMMC-7721 cells released from P6+ hydrogel; All cell capture efficiencies and cell viability were calculated as mean and standard deviation from 6 independent experiments; (c) Photographs of P6+ hydrogel rapidly recovering to its original shape after applying and releasing compressive forces; (d) Stress changes experienced by CTCs as they adapt to the extracellular matrix (ECM), and the different storage moduli of P4 and P6 hydrogels.
[0025] Figure 1 Identification of recognition sites on liver cancer tumor cells using P1 packing material. The experiment on the structure and site information of polysaccharide modification on the surface of liver cancer tumor cells using P1 packing material was conducted according to... Figure 1 The procedure described in section a involves the extraction, lysis, desalting, glycopeptide enrichment, mass spectrometry detection, and database search for mass spectrometry analysis of membrane proteins in a liver cancer model cell (SMMC-7721). Specific experimental procedures are described below.
[0026] 1. Extraction of liver cancer tumor cell membrane proteins
[0027] To collect membrane proteins from the surface of liver cancer tumor cells (SMMC-7721), it is necessary to... 6 Digested healthy cells and centrifuged at 1000 rpm for 5 min. Membrane proteins were extracted from SMMC-7721 cells according to the requirements of the mammalian membrane protein extraction kit (Thermo Scientific Mem-PER Plus, Thermo Scientific, 89842). Specific experimental procedures are as follows: 5 x 10⁻⁶ cells were... 6 The cell pellet was resuspended in 3 mL of cell washing buffer. After centrifuging the cells and collecting the supernatant, the cell pellet was resuspended again in 1.5 mL of cell washing buffer. After centrifuging the cells and collecting the supernatant, the cell pellet was resuspended in 0.8 mL of permeabilization solution, vortexed, and incubated at 4 °C for 10 min, then mixed. The solution was centrifuged at 16000 g for 15 min at 4 °C. Subsequently, the cytoplasmic protein supernatant was collected, and the cell pellet was resuspended in 0.5 mL of dissolving solution, lysed, and incubated at 4 °C for 30 min, then mixed. Finally, the supernatant was collected after centrifugation at 16000 g for 15 min at 4 °C, which is the membrane protein solution. The membrane protein lyophilized powder was then freeze-dried and stored at -80 °C.
[0028] 2. Membrane protein trypsin cleavage
[0029] Membrane protein (1 mg) was dissolved in urea aqueous solution (6 M, 100 μL). Dithiothreitol (5 μL, 200 mM) was added to the urea solution, and the mixture was incubated at 56 °C for 45 min to disrupt the disulfide bonds in the membrane protein. Then, iodoacetic acid (20 μL, 200 mM) was added, and the solution was stored at room temperature in the dark for 30 min. Subsequently, 30 μg of trypsin was added, and the reaction was carried out at 37 °C for 16 h to fully digest and lyse the protein. The reaction was terminated by adding formic acid to a final concentration of 1%. The urea, dithiothreitol, and iodoacetic acid solutions were all prepared using 50 mM NH4HCO3 (pH 8.2) solution.
[0030] 3. Desalting the protein lysis buffer
[0031] Weigh 1 mg of C18 silica sphere material (Fresh Bioscience, SU2-096-025), add 20 μL of acetonitrile, mix well, and uniformly pressurize and fill into an SPE column (Thermo Scientific, Eppendorf) plugged with a single layer of 3M C18 membrane. TM GELoader TM Tips, 10411193). The obtained SPE column was first activated with 20 μL of 50% acetonitrile / 0.1% formic acid (0.5 mL ultrapure water + 0.5 mL acetonitrile + 1 μL formic acid) solution, then equilibrated with 20 μL of 0.1% formic acid (1.0 mL ultrapure water + 1 μL formic acid). The enzymatic hydrolysate was then added to the SPE column. Subsequently, various salts were washed with 40 μL of 0.1% formic acid (1.0 mL ultrapure water + 1 μL formic acid) solution, and trypsin peptides were released with 20 μL of 50% acetonitrile / 0.1% formic acid (0.5 mL ultrapure water + 0.5 mL acetonitrile + 1 μL formic acid) solution. Finally, the trypsin peptides were freeze-dried to obtain trypsin peptide lyophilized powder and stored at -80℃ for enrichment with P1 packing material.
[0032] 4. P1 filler glycopeptide enrichment
[0033] First, P1 packing material (2 mg) was suspended in 20 μL of acetonitrile. Then, 20 μL of trypsin peptide solution (1 mg of lyophilized and desalted trypsin peptide powder dissolved in a mixture of 0.85 mL acetonitrile and 0.15 mL 50 mM NH4HCO3) was loaded onto the P1 packing material. The material was then washed sequentially with 20 μL of 72% acetonitrile / 50 mM NH4HCO3 (0.72 mL acetonitrile and 0.28 mL 50 mM NH4HCO3) and 70% acetonitrile / 50 mM NH4HCO3 (0.70 mL acetonitrile and 0.30 mL 50 mM NH4HCO3). Finally, the material was eluted with 20 μL of 50% acetonitrile / 0.1% formic acid (0.5 mL ultrapure water + 0.5 mL acetonitrile + 1 μL formic acid). The final eluent was collected for mass spectrometry analysis.
[0034] 5. LC-MS / MS testing
[0035] Using EASY-nLC TM A 1200 ultra-high performance liquid chromatography system (Thermo Fisher Scientific, USA) and a Q Exactive HF-X mass spectrometer (Thermo Fisher Scientific, USA) were used to detect peptide fractions of proteins digested by trypsin. First, the lyophilized sample was redissolved in 0.1% formic acid (1.0 mL ultrapure water + 1 μL formic acid), and then the sample was extracted for analysis. The flow rate was fixed at 300 nL / min. Mobile phase A was an ultrapure aqueous solution of 0.1% formic acid (1.0 mL ultrapure water + 1 μL formic acid); mobile phase B was an acetonitrile solution containing 0.1% formic acid (1.0 mL acetonitrile + 1 μL formic acid). The following binary separation gradient was used: 3% to 5% buffer B, 5s; 5% to 15% buffer B, 23min 55s; 15% to 28% buffer B, 21min; 28% to 38% buffer B, 7min 30s; 38% to 100% buffer B, 5s; 100% buffer B, 12min 25s.
[0036] After elution and ionization, the peptides were connected in tandem to a Q Exactive HF-X mass spectrometer for analysis. The ion source voltage was set to 2 kV, and high-resolution Orbitrap was used to detect and analyze the peptide precursor ion and its secondary fragments. The primary mass spectrometry scan range was set to 350–1500 m / z with a scan resolution of 60,000, and the secondary scan resolution was set to 15,000. The mass spectrometer was operated in positive ion data correlation acquisition (DDA) mode, with primary automatic gain control (AGC) set to 3E6, secondary AGC set to 1E5, and the tandem mass spectrometry scan dynamic exclusion time set to 30 s.
[0037] 6. Mass spectrometry data analysis
[0038] When searching for Glyco-Decipher (Glyco-Decipher-v1.0.4) to analyze MS data, the following criteria were used: Enzyme: complete trypsin digestion, maximum missed digestion count of 3; urea methylation at C was set as a fixed modification; oxidation at M was set as a variable modification; precursor mass tolerance: 5 ppm; fragment mass tolerance: 20 ppm. The HomoSapiens Protein database from UniProt was used. Since FDR screening was performed in the procedure, the StrucGP GPSM results were immediately used in subsequent analyses.
[0039] 7. Analysis of Glycan Modification Structure and Site Information
[0040] Using Glyco-Decipher-v1.0.4 software and searching MS data against the UniProt human database, a total of 54 glycopeptides (GPs) were identified by MS. Their sequence and glycosylation site information is listed in a separate Excel spreadsheet, which is not provided here, but its authenticity and validity are guaranteed. Figure 1 b shows the types and proportions of identified GPs. P1 filler showed a strong preference for sialylated GPs; 85% of the identified GPs were modified with bibranched sialylated glycopeptides (SGPs), while only 9% were modified with oligomannose-type glycans. Based on this characteristic, CTC-capturing materials prepared using DPBA can selectively bind to hepatocellular carcinoma CTCs, rather than to erythrocytes, leukocytes, or epithelial cells, because the cell membranes of these cells exhibit glycan expression different from the identified results. Using the peptide sequences obtained from the search, a total of 75 glycoproteins were identified from the UniProt database, with their ID numbers at [ID number missing in original text]. Figure 1 As shown in b. To assess the potential pathogenicity of these glycoproteins, protein and transcriptome-level analyses were performed using the Human Protein Atlas database. Figure 1 As shown in Figure c, eight genes encoding glycoproteins were found to be associated with liver cancer among these 75 glycoproteins. The corresponding protein and RNA expression levels were graded based on information from the Human Protein Atlas database. Among these genes, complement factor B (CFB) and ceruloplasmin (CP) showed significant upregulation at both the protein and RNA levels, indicating liver cancer involvement. In contrast, other identified genes showed upregulation at only one of these levels. By combining data from the UniProt and PDB databases, Asn(s) in CFB were identified. 107 And Asn in CP 358 Modified by bi-branch SG ( Figure 1d). Therefore, it can be inferred that DPBA may bind to these glycans in CFB and CP, laying the foundation for designing capture materials targeting SMMC-7721 cells.
[0041] Figure 2 Intelligent responsive hydrogel P6+ clinical liver cancer detection and the combined use of two indicators to improve diagnostic efficiency.
[0042] 1. P6+ hydrogel CTC detection in liver cancer patients
[0043] Based on the background survey, we enrolled 24 clinical samples with AFP levels less than 20 ng / mL, including 13 patients with liver cancer, 7 patients with cirrhosis, and 4 healthy volunteers.
[0044] The experimental procedure is described using one patient and P6+ hydrogel as an example:
[0045] A 5 ml whole blood sample (purple blood collection tube, collected immediately) was obtained from the Second Affiliated Hospital of Dalian Medical University. The blood was centrifuged at 450 g for 5 minutes to remove serum, and plasma was collected. Since the volume of 5 ml of blood is much larger than the capacity of the hydrogel, the collected plasma was used to lyse red blood cells using erythrocyte lysis buffer (0.8 g ammonium chloride (NH4Cl), 37 mg ethylenediaminetetraacetic acid (EDTA), 84 mg sodium bicarbonate (NaHCO3), and 100 ml deionized water). Ten times the volume of the erythrocyte lysis buffer was added to the plasma, and the mixture was gently vortexed and lysed for 5 minutes. The plasma was centrifuged at 450 g for 5 minutes at 4°C, the red supernatant was discarded, and ten times the volume of the remaining cells was added to phosphate buffer to resuspend the precipitate. The resuspended precipitate was centrifuged at 450 g for 3 minutes, and the supernatant was discarded. The pellet was resuspended in 1 mL of cell culture medium [89% Dulbecco's modified eagle medium, DMEM (Gibco), 10% Fetal bovine serum, FBS (ExCell Bio), and 1% penicillin-streptomycin, 100X (Beyotime; the cell culture medium composition is the same as described here], and evenly inoculated (dropped onto the gel surface) onto the surface of the P6+ hydrogel (area: 14 cm²). 2After placing the cells (height: 0.7 cm) in a cell culture incubator for 1 hour, the surface of the P6+ hydrogel was slowly rinsed with 1 mL of phosphate buffered solution to remove residual red blood cells and unbound cells. During this time, 10 μL of fluorescein isothiocyanate-labeled epithelial cell adhesion molecule antibody (FITC) anti-human CD326 (epithelial cell adhesion molecule, EpCAM) Antibody (Enabling Legendary Discovery, 369814), 10 μL of phycoerythrin-labeled phosphatidylinositol polysaccharide 3 (PE) anti-human Glypican-3 (GPC 3) Antibody (abcam, 14610063), and 0.4 μL of 4',6-diamidino-2-phenylindole (DAPI) (Invitrogen) were added. TM Add D1306 to 1 mL of PBS solution and vortex for 3 minutes. Evenly drop the solution onto the surface of the P6+ hydrogel and stain at room temperature for 30 minutes. Then, slowly rinse the P6+ hydrogel surface with 1 mL of PBS solution, repeating the rinsing operation 3 times. Invert the P6+ hydrogel surface downwards (so that the surface of the rinsed P6+ hydrogel is facing down) and place it under an inverted research fluorescence microscope (Nikon Ti-s, Japan). Select the FITC channel (excitation wavelength: 488 nm; emission wavelength: 512 nm), PE channel (excitation wavelength: 488 nm; emission wavelength: 578 nm), and DAPI channel (excitation wavelength: 364 nm; emission wavelength: 456 nm) to observe and record the number of circulating tumor cells. Here, AFP (provided by the hospital) and CTC (P6+ hydrogel capture) can be considered as two different classification indicators for liver cancer (the specific data is too large to be provided in the text, but the data's authenticity and reliability are guaranteed).
[0046] 2. Data Analysis
[0047] like Figure 2 As shown in Figure a, the P6+ hydrogel effectively extracted 1–7 CTCs from a 5 mL blood sample from a liver cancer patient. In contrast, only one CTC was detected in a blood sample from a cirrhotic patient, while no CTCs were found in blood samples from other cirrhotic patients or non-cancer volunteers. These results demonstrate the clinical applicability and reliability of the P6+ hydrogel-based CTC capture method. Furthermore, the cutoff value for CTC counting was 1.5 (…). Figure 2(b) It can distinguish between cancer patients and non-cancer patients. Data from two indicators, AFP and CTC, were input into a random forest model (neural network) in a deep learning model for data integration and analysis. Data from 24 samples (13 liver cancer patients, 7 cirrhosis patients, and 4 healthy volunteers) were included in the model system, and the cancer discrimination ability was determined using a binary classification model—receiver operating characteristic (ROC) curve. Figure 2 c). The area under the ROC curve (AUC) values (AFP: 0.439; CTC: 0.996; AFP+CTC: 0.998) demonstrate that the combined use of the two indicators can improve the ability to differentiate liver cancer. Additionally, a large number of white blood cells in human blood interfere with CTC capture (…). Figure 2 d), therefore, the capture efficiency of the P6+ hydrogel for leukocytes was measured, and the results showed that it was only 0.13 ± 0.03‰, which is negligible for downstream CTC counting. Figure 2 d). Detailed Implementation
[0048] Raw materials used in the examples:
[0049] 6-Bromo-1-hexene, 2-formylphenylboronic acid, 3-mercaptopropyltrimethoxysilane, diethyl pyridine-3,5-dicarboxylic acid, fluorescein isothiocyanate, 10-hydroxybenzo[h]quinoline (HBQ), and 2,2-azobis(2-methylpropanediidine) hydrochloride (AIBA) were purchased from Shanghai Aladdin Reagent Co., Ltd. Polyethylene glycol dimethacrylate (PEGDMA), polyethylene glycol methacrylate (PEGMA), 3-aminophenylboronic acid, and human serum albumin were purchased from Sigma-Aldrich Corp. (St. Louis, Missouri, USA). Acryloyl chloride, methanol, sodium hydroxide, and hydrochloric acid were purchased from Thermo Fisher Scientific. Other solvents and reagents were purchased from Sinopharm Chemical Reagent Co., Ltd. The water used in this study was ultrapure water obtained from the Milli-Q system. 1 Hspectra was obtained using an AVANCE III HD 700MHz spectrometer. Infrared data were obtained using a Tensor II Fourier transform infrared spectrometer. Fluorescence spectra were obtained using a fluorescence spectrophotometer (RF-6000). Mass spectrometry data were obtained using a QExactive HF-X mass spectrometer and an Orbitrap Exploris 480 mass spectrometer.
[0050] Example 1
[0051] Synthesis of flexible two-arm phenylboronic acid 3,5-bis((2-((2-phenylboronic acid)amino)ethyl)carbamoyl)-1-(hex-5-en-1-yl)pyridine (DPBA).
[0052]
[0053] (1) Synthesis of 3,5-di(ethoxycarbonyl)-1-(hex-5-en-1-yl)pyridine: Diethyl pyridine-3,5-dicarboxylic acid (500 mg, 2.2 mmol) and 6-bromo-1-hexene (420 mg, 2.6 mmol) were dissolved in anhydrous DMF at 100 °C under N2 protection, stirred for 12 h, and cooled to 25 °C. Reversed-phase HPLC purification was performed using a C18 semi-preparative column (Huapu Scientific, 10X 250x Aqua) with a UV detector at 254 nm. Mobile phase A was ultrapure water with a volume concentration of 0.1% trifluoroacetic acid, and mobile phase B was methanol with a volume concentration of 0.1% trifluoroacetic acid. Gradient elution conditions were applied, with mobile phase B increasing from 10% to 90% within 40 minutes. The fraction corresponding to the peak at 14.8 min was collected, rotary evaporated under reduced pressure, and freeze-dried to obtain a yellow powder of 3,5-di(ethoxycarbonyl)-1-(hex-5-en-1-yl)pyridine (206.8 mg), with a yield of 30.1%. The infrared, mass spectrometry, and NMR data are as follows: Fourier-transform infrared (FT-IR): 3004, 2925, 1909, 1749, 1628, 1591, 1519, 1406, 1327, 1268, 1222, 1194, 1054, 990, 970, 797 cm⁻¹ -1 . Quadrupole Time–of–Flight Mass Spectrometry(Q–TOF–MS)m / z for(C 17 H 24 NO4 + Theoretical value [M+H] + 306.38; Actual value: 306.16. Amplified hydrogen nuclear magnetic resonance ( 1 H NMR)(400MHz,DMSO-d6)δ9.62(s,1H,Ar–H),9.56(s,1H,Ar–H),9.12(s,1H,Ar– H),5.81–5.78(m,1H,–CH=C),5.02(d,J=16Hz,1H,–C=CH),4.99–4.90(m,2H,–N +–CH2–),4.81(d,J=6Hz,1H,–C=CH),4.03–4.00(m,2H,–O–CH2–),3.99–3.97(m,2H,–O–CH 2–), 2.08–2.01(m,2H,–CH2–), 1.97–1.87(m,2H,–CH2–), 1.49–0.98(m,8H,–CH2–,CH3).
[0054] (2) Synthesis of 3,5-bis((2-aminoethyl)carbamoyl)-1-(hex-5-en-1-yl)pyridine: 3,5-bis(ethoxycarbonyl)-1-(hex-5-en-1-yl)pyridine (200 mg, 0.7 mmol) and ethylenediamine (1.0 g, 16.6 mmol) were dissolved in 20 mL of anhydrous methanol at 25 °C and stirred for 24 h. The reaction mixture was concentrated under vacuum, and the crude product was washed three times with methanol to remove residual ethylenediamine, finally yielding 187.2 mg of yellow powder 3,5-bis((2-aminoethyl)carbamoyl)-1-(hex-5-en-1-yl)pyridine in a yield of 85.9%. Infrared, mass spectrometry, and nuclear magnetic resonance data are as follows: FT–IR: 3163, 2986, 2907, 1812, 1730, 1679, 1649, 1589, 1560, 1420, 1362, 1330, 1275, 1214, 1196, 1141, 1105, 983, 888 cm⁻¹ -1 Q–TOF–MSm / z for(C 17 H 28 N5O2 + Theoretical value [M+H] + 335.23; Actual value: 335.16. 1 H NMR(400MHz,DMSO-d6)δ8.04(s,1H,Ar–H),8.00(s,2H,–NH–,–NH–),7.34(s,1H,Ar–H),7.07( s,1H,Ar–H),6.17(t,J=10.8Hz,1H,–CH=C),4.15(d,J=16Hz,1H,–C=CH),4.07–4.00(m,2H,–N +–CH2–),3.79(d,J=5.5Hz,1H,–C=CH),3.26(t,J=6.1Hz,2H,–N–CH2–),3.18(t,J=6.0Hz,2H,–N–CH2–),3.13–3.09(m,2H ,–CH2–N–),3.07–2.99(m,2H,–CH2–N–),2.73–2.68(m,2H,–CH2–),2.57–2.53(m,2H,–CH2–),1.26–1.23(m,2H,–CH2–).
[0055] (3) Synthesis of flexible two-arm phenylboronic acid: 2-Formylphenylboronic acid (150 mg, 1.0 mmol) was dissolved in anhydrous methanol (10 mL) at 0 °C and N2 conditions to obtain a reaction mixture. 1 mL of anhydrous methanol containing 3,5-bis((2-aminoethyl)carbamoyl)-1-(hex-5-en-1-yl)pyridine (180 mg, 0.5 mmol) was added dropwise to the reaction mixture using a 1 mL syringe. The mixture was stirred at 0 °C for 15 min, and then stirred at room temperature for 4 h. The mixture was cooled again to 0 °C, and NaBH4 (0.2 g, 5.0 mmol) was slowly added. The mixture was then stirred at room temperature for 1 h. The reaction mixture was rotary evaporated under reduced pressure to 1 / 3 of its original volume. Deionized water (0 °C, 5 mL) and a saturated NaHCO3 aqueous solution (5 mL) were added to the concentrated solution, and the mixture was stirred for 10 min. The reaction solution was extracted three times with dichloromethane (50 mL), the organic phase was dried over sodium sulfate, rotary evaporated under reduced pressure and freeze-dried, finally yielding a yellow powder of DPBA (246.8 mg), with a yield of 76.1%. The FT-IR, mass spectrometry, and NMR data are as follows: FT-IR: 3614, 3376, 2995, 2861, 1668, 1601, 1570, 1542, 1447, 1415, 1345, 1298, 1294, 1265, 1209, 1184, 1151, 1097, 1038, 930, 872, 790, 744 cm⁻¹ -1 Q–TOF–MSm / z for(C 31 H 42 B2N5O6 + Theoretical value [M+H] + 603.33; Actual value: 603.29. 1H NMR(400MHz,DMSO-d6)δ7.99(s,1H,–NH–),7.29(s,1H,Ar–H),7.24(s,1H,Ar–H),7.13(s,1H,Ar–H),7.08–7.07(m,2H,Ar–H), 7.16–7.05(m,6H,Ar–H),6.84(s,1H,–NH–),6.40(d,J=28.6Hz,1H,–CH=C),4.87(d,J=19.1Hz,1H,–C=CH),4.78–4.70(m,2H,–N + –CH2–),4.62(d,J=8.4Hz,1H,–C=CH),4.22(dd,J=20.3,11.3Hz,2H,–NH–,–NH–),3.99(d,J=12.9Hz,2H,Ar–CH2–),3.82(d,J=15.2Hz,2H,Ar–CH2– ),3.17–2.91(m,8H,C2H4,C2H4),2.62–2.61(m,2H,–CH2–),2.54–2.51(m,2H,–CH2–),2.06(d,J=33.5Hz,1H,–CH–),1.25(d,J=12.6Hz,1H,–CH–).
[0056] Example 2
[0057] Synthesis of rigid two-arm phenylboronic acid 3,5-bis(2-(2-phenylboronic acid)hydrazide-1-carbonyl)-1-(hex-5-en-1-yl)pyridine (DPBH).
[0058]
[0059] (1) Synthesis of 3,5-di(ethoxycarbonyl)-1-(hex-5-en-1-yl)pyridine: Diethyl pyridine-3,5-dicarboxylic acid (500 mg, 2.2 mmol) and 6-bromo-1-hexene (420 mg, 2.6 mmol) were dissolved in anhydrous DMF at 100 °C under N2 protection. The mixture was stirred for 12 h, cooled to 25 °C, and purified by reversed-phase HPLC using a C18 semi-preparative column (Huapu Scientific Instruments, 10X 250x Aqua). The detector was a UV detector at 254 nm. Mobile phase A was ultrapure water with a volume concentration of 0.1% trifluoroacetic acid, and mobile phase B was methanol with a volume concentration of 0.1% trifluoroacetic acid. The gradient elution conditions were that mobile phase B increased from 10% to 90% within 40 minutes. The fraction corresponding to the peak at 14.8 min was collected, rotary evaporated under reduced pressure, and freeze-dried to obtain a yellow powder of 3,5-di(ethoxycarbonyl)-1-(hex-5-en-1-yl)pyridine (206.8 mg), with a yield of 30.1%. Infrared, mass spectrometry, and NMR data are as follows: FT–IR: 3004, 2925, 1909, 1749, 1628, 1591, 1519, 1406, 1327, 1268, 1222, 1194, 1054, 990, 970, 797 cm⁻¹ -1 Q–TOF–MSm / z for(C 17 H 24 NO4 + Theoretical value [M+H] + 306.38; Actual value: 306.16. 1 H NMR(400MHz,DMSO-d6)δ9.62(s,1H,Ar–H),9.56(s,1H,Ar–H),9.12(s,1H,Ar– H),5.81–5.78(m,1H,–CH=C),5.02(d,J=16Hz,1H,–C=CH),4.99–4.90(m,2H,–N + –CH2–),4.81(d,J=6Hz,1H,–C=CH),4.03–4.00(m,2H,–O–CH2–),3.99–3.97(m,2H,–O–CH 2–), 2.08–2.01(m,2H,–CH2–), 1.97–1.87(m,2H,–CH2–), 1.49–0.98(m,8H,–CH2–,CH3).
[0060] (2) Synthesis of 3,5-di(hydrazine carbonyl)-1-(hex-5-en-1-yl)pyridine: 3,5-di(ethoxycarbonyl)-1-(hex-5-en-1-yl)pyridine (600 mg, 2.0 mmol) and hydrazine hydrate (0.5 mL) were dissolved in 20 mL of anhydrous methanol at 25 °C and stirred for 24 h. The reaction solution was rotary evaporated under reduced pressure to 1 / 3 of its original volume. Deionized water (0 °C, 50 mL) was added to the above concentrated solution, and stirring was continued for 30 min. Finally, the resulting solution was centrifuged and dried by vacuum freeze-drying to obtain a yellow powder of 3,5-di(hydrazine carbonyl)-1-(hex-5-en-1-yl)pyridine (206.4 mg), with a yield of 94.7%. Infrared, mass spectrometry, and nuclear magnetic resonance data are as follows: FT–IR: 3133, 2996, 2914, 1829, 1739, 1679, 1643, 1578, 1556, 1417, 1360, 1327, 1266, 1208, 1172, 1143, 1105, 977, 885 cm⁻¹ -1 Q–TOF–MSm / z for(C 13 H 20 N5O2 + Theoretical value [M+H] + 278.34; Actual value: 278.16. 1 H NMR(400MHz,DMSO-d6)δ9.74(d,2H,Ar–H,Ar–H),9.31(t,2H,–NH–,–NH–),8.62(t,1H,Ar–H),5 .79(tt,1H,C=CH),5.10(ddt,J=10.8Hz,1H,CH=C),4.98(ddt,J=16Hz,1H,CH=C),4.67(t,2H,–N + –CH2–),4.32(d,2H,–NH2),2.11(m,2H,–CH2–),1.52(m,2H,–CH2–).
[0061] (3) Synthesis of rigid two-arm phenylboronic acid: 2-Formylphenylboronic acid (150 mg, 1.0 mmol) was dissolved in anhydrous methanol (10 mL) at 0 °C and N2 conditions to obtain a reaction mixture. 1 mL of anhydrous methanol containing 3,5-di(hydrazine carbonyl)-1-(hex-5-en-1-yl)pyridine (180 mg, 0.5 mmol) was added dropwise to the reaction mixture using a 1 mL syringe. The mixture was stirred at 0 °C for 15 min, and then stirred at room temperature for 4 h. The mixture was cooled again to 0 °C, and NaBH4 (0.2 g, 5.0 mmol) was slowly added. The mixture was then stirred at room temperature for 1 h. The reaction mixture was rotary evaporated under reduced pressure to 1 / 3 of its original volume. Deionized water (0 °C, 5 mL) and a saturated NaHCO3 aqueous solution (5 mL) were added to the concentrated solution, and the mixture was stirred for 10 min. The reaction solution was extracted three times with dichloromethane (50 mL), the organic phase was dried over sodium sulfate, rotary evaporated under reduced pressure and freeze-dried, finally yielding a yellow powder DPBH (499.1 mg), with a yield of 91.2%. FT-IR, mass spectrometry, and NMR data are as follows: FT-IR: 3633, 3371, 2988, 2860, 1659, 1602, 1570, 1541, 1445, 1410, 1350, 1295, 1294, 1263, 1207, 1185, 1148, 1093, 1035, 930, 869, 783, 739 cm⁻¹ -1 Q–TOF–MSm / zfor(C 27 H 34 B2N5O6 + Theoretical value [M+H] + 546.27; Actual value: 546.22. 1 H NMR(400MHz,DMSO-d6)δ9.72(d,2H,Ar–H,Ar–H),8.59(t,1H,Ar–H),7.62(m,2H,Ar–H),7.42(tdd,2H,Ar–H),7.20(m,4H,Ar–H),7.06(s ,1H,–NH–),5.79(tt,1H,–CH=C),5.32(dt,J=20.3,11.3Hz,2H,–NH–,–NH–),5.12(ddt,1H,–CH=C),4.97(ddt,2H,–CH=C),4.67(t,1H,–N + –CH–), 4.21 (dd, 2H, –NH–CH), 2.11 (m, 2H, –CH2–), 1.52 (m, J = 33.5Hz, 1H, –CH–).
[0062] Example 3
[0063] Affinity determination of flexible two-arm phenylboronic acid and rigid two-arm phenylboronic acid with sialic acid.
[0064] First, stock solutions of 10-hydroxybenzo[h]quinoline (HBQ, 10 mM), PBA (10 mM), DPBA (10 mM), DPBH (10 mM), and Neu5Ac (20 mM) were prepared. Fluorescence spectroscopy was performed at room temperature in a water / DMSO (4:1 volume ratio) test solution. 15 μL of HBQ stock solution was added to 3 mL of test solution, and the spectral data were recorded after 15 min as the initial curve. Subsequently, 6, 12, 18, 24, and 30.0 μL of PBA (10 mM), DPBA (10 mM), and DPBH (10 mM) were added sequentially, and spectral data were obtained. The spectral data of DPBA were plotted, and the fluorescence intensity of PBA (10 mM), DPBA (10 mM), and DPBH (10 mM) was calculated as a function of the added amount. Subsequently, concentrations of PBA (10 mM), DPBA (10 mM), DPBH (10 mM), and (HBQ, 10 mM) in a molar ratio of 2:1 were added to Neu5Ac (20 mM) at concentrations of 8, 18, 36, 70, and 145 μL, respectively. The trends of fluorescence intensity versus molar amount were calculated, and fluorescence curves of HBQ, DPBA, and Neu5Ac were plotted. The test conditions were as follows: excitation wavelength (λ... ex The curve of emission wavelength from 400 to 700 nm was measured at 370 nm and slit width of 3.0 / 5.0 nm.
[0065] 10-Hydroxybenzo[h]quinoline is a typical excited-state intramolecular proton transfer (ESIPT) molecule. Its ground state is enol (emission wavelength 506 nm), and upon excitation, it transforms into a keto tautomer with an emission wavelength of 593 nm. PBA disrupts the ESIPT of HBQ by forming a coordination bond with it. The DPBA-HBQ complex emits a strong fluorescence peak at 506 nm, and the fluorescence intensity gradually increases with the addition of DPBA. Figure 3 a). Subsequently, Neu5Ac was added to the PBA-HBQ solution. DPBA competitively binds to Neu5Ac, causing HBQ to be released from the DPBA-HBQ complex, resulting in a rapid decrease in the emission peak intensity at 506 nm. Figure 3 b). This indicates a strong interaction between DPBA and Neu5Ac. Furthermore, the performance of DPBA and PBA was compared, such as... Figure 3 As shown in Figure c, the binding of DPBA to HBQ results in a faster increase in fluorescence intensity than the interaction between PBA and HBQ. This difference can be reasonably attributed to the presence of more PBA groups in DPBA, thereby enhancing its interaction with HBQ. Furthermore, the complexation of DPBA with Neu5Ac is stronger than that with PBA, as evidenced by the rapid and sharp decrease in fluorescence intensity of DPBA-HBQ. Figure 3d), while the corresponding curve for PBA-HBQ shows a smoother decrease. To further verify the role of the flexible ethylenediamine arm in DPBA, the rigid reference molecule DPBH was synthesized (scheme S3 and figure S1a), in which hydrazine was used as the connecting arm. Figure 3 As shown by the blue lines in c and 3d, the changes caused by DPBH are significantly smaller than those caused by DPBA, highlighting the advantages of the flexible connector in DPBA in terms of object bonding.
[0066] Example 4
[0067] Affinity determination of flexible two-arm phenylboronic acid and bibranched sialylated glycan
[0068] The interaction affinity between HH and Neu5Ac was determined using the Octet K2 system combined with an amine reactive second-generation (AR2G) biosensor (Sartorius, 18-5092) based on biolayer interferometry (BLI). BLI is a label-free, real-time optical detection technique capable of dynamically monitoring the entire molecular binding process and accurately calculating key parameters during the reaction, widely used in biomolecular interaction research. The detection principle of BLI is based on the real-time monitoring of changes in the optical layer thickness by the AR2G fiber optic biosensor. When the analyte specifically binds to the sensor tip, a biofilm layer is formed, the thickness of which changes with the binding of the analyte and ligand. When light irradiates the biofilm layer, the change in biofilm thickness leads to a change in displacement (nm). By detecting the real-time displacement (nm) data before and after analyte binding, the strength of intermolecular interactions can be analyzed. The AR2G biosensor has a high-density carboxylic acid group-modified surface, which effectively reduces non-specific interactions. Immobilization of the analyte is achieved by catalyzing the formation of amide bonds, which covalently binds the reactive amine groups to the carboxyl terminus on the biosensor surface. After activation and immobilization, excess NHS esters on the biosensor surface are quenched with ethanolamine to further reduce nonspecific binding.
[0069] The specific experimental procedure is as follows: First, N-ethyl-N'-(3-dimethylaminopropyl)carbodiimide (30 mg) and N-hydroxysuccinimide (18 mg) were dissolved in 400 μL of ultrapure water to obtain an activation solution, which was then transferred to a 96-well plate, with 200 μL of the solution added to each well. Two AR2G biosensors were placed in the wells containing the activation solution at room temperature in the dark. After 2 hours, the solution in the wells was discarded. 2 mg of amino-modified Neu5Ac-α-Gal-β-Glc or bibranched sialylated glycopeptide (CAS No.: 189035-43-6) was dissolved in 400 μL of ultrapure water and added to the wells. The two AR2G biosensors were then placed in the wells containing the amino-modified Neu5Ac-α-Gal-β-Glc or bibranched sialylated glycopeptide (CAS No.: 189035-43-6) solution, and allowed to react for 24 hours at room temperature in the dark. Utilizing the amino groups in the molecule, amino-modified Neu5Ac-α-Gal-β-Glc or a bibranched sialylated glycopeptide (CAS No.: 189035-43-6) was covalently grafted onto the carboxyl-terminated AR2G surface via an amidation reaction. Subsequently, the AR2G surface was thoroughly washed with ultrapure water to remove unreacted sample. Simultaneously, stock solutions of PBA (1 mg / mL), DPBA (1 mg / mL), and DPBH (1 mg / mL) were prepared and diluted to obtain test solutions with different concentration gradients (3, 6, 12, 25, and 50 μM). The experimental group (one AR2G) was exposed to the test solutions of different concentration gradients, and binding, dissociation, and interaction analyses were performed at 20 °C. Simultaneously, a control group (another AR2G) was exposed to ultrapure water for a control experiment under the same conditions. Experimental data were analyzed using ForteBio Data Analysis 11.0 software.
[0070] This experiment demonstrated the adsorption of Neu5Ac-α-Gal-β-Glc onto the surface of the BLI sensor after immobilization via a condensation reaction. Figure 4 a) and nonlinear fitting ( Figure 4 b) Data shows the dissociation constant (K) D The concentration was 2.3 μM. Furthermore, bibranched sialylated glycan (CAS No.: 189035-43-6) was immobilized on the surface of the BLI sensor, and then the sensor was adsorbed using solutions of different concentrations of DPBA, DPBH, or PBA. Figure 4 As shown in Figure c, the dynamic response curves demonstrate that DPBA adsorbs rapidly and strongly on the sensor surface modified with bibranched sialylated glycans, corresponding to a high binding rate constant (K0). on Meanwhile, a lower dissociation rate constant (Ka) was observed when DPBA was eluted from the sensor surface.off Nonlinear fitting of the data ( Figure 4 d) The K-axis of the interaction between DPBA and bibranched sialylated glycans was obtained. D (K off / K on The concentration was 0.2 μM. In contrast, under the same conditions, the adsorption of PBA or DPBH produced only a weak response, resulting in K... D The values were 1.5 or 6.5 μM, respectively, indicating that their binding affinity to bibranched sialylated glycans was significantly lower than that of DPBA.
[0071] Example 5
[0072] P1 filler was synthesized by surface grafting of a silane coupling agent followed by a sulfur bond chemical reaction. Specifically, 3-mercaptopropyltrimethoxysilane was grafted onto the surface of silica microspheres to expose thiol groups. Subsequently, DPBA was introduced through a sulfur bond chemical reaction between the thiol and alkenyl groups in DPBA to obtain the P1 filler.
[0073]
[0074] (1) Synthesis of mercaptopropyl modified silica (SH@SiO2): 1.0 g of silica microspheres (10 μm in diameter, with a porosity of 10 μm) were prepared. The silica microspheres were suspended in HNO3 (15% by mass, 5 mL) for 10 h to generate a sufficient number of hydroxyl groups on the surface of the silica microspheres. The hydroxylated silica microspheres were then separated by centrifugation at 6000 rpm for 5 min, washed five times with ultrapure water, and freeze-dried. The hydroxylated silica microspheres (500 mg) were dispersed in 5 mL of anhydrous toluene and 0.5 mL of 3-mercaptopropyltrimethoxysilane. The reaction mixture was refluxed at 110 °C for 24 h. The resulting silica microspheres (SH@SiO2) were separated by centrifugation at 6000 rpm for 5 min and then subjected to three separate dispersion and precipitation washes in toluene, methanol, ultrapure water, and methanol, respectively. Finally, SH@SiO2 microspheres were obtained by vacuum freeze-drying.
[0075] (2) Synthesis of P1 filler: To immobilize the bibranched sialylated polysaccharide-binding unit DPBA on the surface of silica microspheres, SH@SiO2 (50 mg), DPBA (20 mg), 2,2-azobis(2-methylpropanediamine) hydrochloride (2.4 mg), and triethylamine (15 μL) were added to an ultrapure water / methanol (5 mL, v / v, 1:1) mixture under nitrogen protection. The reaction solution was maintained at 65 °C for 24 h to obtain DPBA@SiO2. These microspheres were collected by centrifugation at 6000 rpm for 10 min, and residual chemicals were removed by repeated dispersion and precipitation cycles (3 times) followed by washing with ultrapure water and methanol. Finally, DPBA@SiO2 silica microspheres were obtained by freeze drying. The successful synthesis of P1 filler was confirmed by thermogravimetric analysis (TGA) and scanning electron microscopy. Figure 5 The content of the sample was 5.92 mg, and the DPBA grafting rate was 16%.
[0076] Example 6
[0077] P1 filler specifically enriches sialic acid glycopeptides in fetal proteins.
[0078] The P1 packing material was used in experiments with standard sialic acid glycoprotein, fetoglobulin, and sialic acid glycopeptide. After protein lysis and desalting, the following procedures were followed: Figure 6 The flowchart for glycopeptide enrichment and mass spectrometry detection described in section a is followed. Specific experimental procedures are described below:
[0079] 1. Protein trypsin cleavage
[0080] Fetoglobulin (1 mg) was dissolved in an aqueous urea solution (6 M, 100 μL). Dithiothreitol (5 μL, 200 mM) was added to the urea solution, and the mixture was incubated at 56 °C for 45 min to disrupt the disulfide bonds in the membrane protein. Then, iodoacetic acid (20 μL, 200 mM) was added, and the solution was stored at room temperature in the dark for 30 min. Subsequently, 30 μg of trypsin was added, and the reaction was carried out at 37 °C for 16 h to fully digest and lyse the protein. The reaction was terminated by adding formic acid to a final concentration of 1%. The urea, dithiothreitol, and iodoacetic acid solutions were all prepared using a 50 mM NH4HCO3 solution (pH 8.2).
[0081] 2. Desalting the protein lysis buffer
[0082] Weigh 1 mg of C18 silica sphere material (Fresh Bioscience, SU2-096-025), add 20 μL of acetonitrile, mix well, and uniformly pressurize and fill into an SPE column (Thermo Scientific, Eppendorf) plugged with a single layer of 3M C18 membrane. TM GELoaderTM Tips, 10411193). The obtained SPE column was first activated with 20 μL of 50% acetonitrile / 0.1% formic acid (0.5 mL ultrapure water + 0.5 mL acetonitrile + 1 μL formic acid) solution, then equilibrated with 20 μL of 0.1% formic acid (1.0 mL ultrapure water + 1 μL formic acid). The enzymatic hydrolysate was then added to the SPE column. Subsequently, various salts were washed with 40 μL of 0.1% formic acid (1.0 mL ultrapure water + 1 μL formic acid) solution, and trypsin peptides were released with 20 μL of 50% acetonitrile / 0.1% formic acid (0.5 mL ultrapure water + 0.5 mL acetonitrile + 1 μL formic acid) solution. Finally, the trypsin peptides were freeze-dried to obtain trypsin peptide lyophilized powder and stored at -80℃ for enrichment with P1 packing material.
[0083] 3. P1 filler glycopeptide enrichment
[0084] First, P1 packing material (2 mg) was suspended in 20 μL of acetonitrile. Then, 20 μL of trypsin peptide solution (1 mg of lyophilized and desalted trypsin peptide powder dissolved in a mixture of 0.85 mL acetonitrile and 0.15 mL 50 mM NH4HCO3) was loaded onto the P1 packing material. The material was then washed sequentially with 20 μL of 72% acetonitrile / 50 mM NH4HCO3 (0.72 mL acetonitrile and 0.28 mL 50 mM NH4HCO3) and 70% acetonitrile / 50 mM NH4HCO3 (0.70 mL acetonitrile and 0.30 mL 50 mM NH4HCO3). Finally, the material was eluted with 20 μL of 50% acetonitrile / 0.1% formic acid (0.5 mL ultrapure water + 0.5 mL acetonitrile + 1 μL formic acid). The final eluent was collected for mass spectrometry analysis.
[0085] 4. High-resolution mass spectrometry testing
[0086] The eluted peptides were separated and analyzed using an LTQ–Orbitrap Elite mass spectrometer equipped with a Dionex UltiMate 3000RSLCnano system. The specific procedures were as follows: The eluent was lyophilized and redissolved in 100 μL of 40% acetonitrile / 5 mM NH4HCO3 (0.40 mL acetonitrile and 0.60 mL 5 mM NH4HCO3) to a concentration of 0.5 mg / mL. Then, 3 μL was pipetted for separation and analysis. The sample was enriched on a C18 capture column (3.5 cm × 200 μm id) and then analyzed on a reversed-phase (RP) C18 analytical column (15 cm × 150 μm id, 1.9 μm). Peptides were separated using a Sunchrom mass spectrometer. The flow rate was set to 400 nL / min. A binary separation gradient was used with the following parameters: Buffer B (80% acetonitrile / 0.1% formic acid) concentration increased from 2% to 8% over 2 min; Buffer B (8% to 45% over 30 min); Buffer B (45% to 95% over 1 min). Positive ion data-dependent acquisition (DDA) mode was used for mass spectrometry. The full MS scan range was set to m / z: 350 to 2000. Collision-induced dissociation (CID) fragmentation was performed on the 20 most abundant precursor signals with the following parameters: minimum intensity 500, isolation width 2, normalized collision energy 35, and dynamic exclusion enabled (1 repetition, 30 s repetition duration, 90 s exclusion duration).
[0087] 5. Spectral Analysis
[0088] Fetoglobulin is a typical glycoprotein with abundant glycosylation sites. It is digested by trypsin into various peptide fragments, including unmodified peptides and glycopeptides. For example... Figure 6 As shown in b, MS identified a total of 33 glycopeptides, including 11 neutral and 22 sialylated glycopeptides. This material showed a preference for sialylated glycopeptides, successfully detecting 4 single-branched, 9 double-branched, and 9 triple-branched sialylated glycopeptides, which dominated the MS spectra. This result indicates that the P1 packing material has the potential to effectively enrich sialylated glycopeptides.
[0089] Example 7
[0090] P2, P3, and P4 hydrogel polymer network backbones were prepared using atom transfer radical polymerization.
[0091]
[0092] (1) Synthesis of poly(ethylene glycol) methyl ethermethacrylate [PPM, P2]: The polymerization method used was free radical random copolymerization. The initiator used was potassium persulfate (KPS, CAS No. 7727-21-1, Sigma-Aldrich Corp.), and the monomer used was polyethylene glycol methyl methacrylate (PEGMA, n=9, CAS No. 25736-86-1, Sigma-Aldrich Corp.). The specific synthesis steps are as follows: PEGMA (26 mL, 60 mmol) was added to a 50 mL EP tube, and 30 mL of ultrapure water was added as a solvent. The mixture was dissolved by sonication and then shaken to mix. Subsequently, initiator KPS (0.4 g, 1.5 mmol) was added, and the mixture was shaken and mixed for 3 hours. The mixture was then poured into a 100 mL glass sample vial, sealed, and placed in an oven. For the first 12 hours, the temperature was maintained at 30 °C. Afterward, the temperature was increased to 80 °C, maintained for 6 hours, and then decreased to 30 °C, continuing this process for 2 days (including the initial 18 hours). The heating and cooling rates were both 10 °C / hour. The glass vial containing P2 was carefully broken, and P2 was removed and immersed in 100 mL of ultrapure water for dialyzing and purification for 10 days to remove unreacted monomers. The immersion solution was changed daily during this period. The successful synthesis of P2 was characterized by FT-IR and EDS elemental analysis (structure shown in the figure above, n = 9, degree of polymerization 8). Number average molecular weight = 8590 Da, polydispersity (PDI) = 0.2. FT-IR: 3400, 2870, 1720, 1454, 1320, 1100 cm⁻¹ -1 ; EDS: 91.61% (C), 8.39% (O).
[0093] (2) Synthesis of poly(ethylene glycol) methyl ether methacrylate-co-poly(ethylene glycol) dimethacrylate [PPM-co-PPEG, P3]: The polymerization method used was free radical random copolymerization. The initiator used was potassium persulfate (KPS, CAS No. 7727-21-1, Sigma-Aldrich Corp.). The monomer used was polyethylene glycol methyl methacrylate (PEGMA, n=9, CAS No. 25736-86-1, Sigma-Aldrich Corp.). The crosslinking agent used was polyethylene glycol dimethacrylate (PEGDMA, n=13, CAS No. 25852-47-5, Sigma-Aldrich Corp.). The specific synthesis steps are as follows: PEGMA (26 mL, 60 mmol) and PEGDMA (0.4 mL, 0.6 mmol) were added to two 50 mL EP tubes, along with 30 mL of ultrapure water as a solvent. The mixture was dissolved by sonication and then shaken to mix. Subsequently, the initiator KPS (0.4 g, 1.5 mmol) was added, and the mixture was shaken to mix for 3 hours. The mixture was then poured into 100 mL glass sample vials, the vials were sealed, and the vials were placed in an oven. For the first 12 hours, the temperature was maintained at 30 °C. Then, the temperature was increased to 80 °C, maintained for 6 hours, and then decreased to 30 °C, continuing this process for 2 days (including the initial 18 hours). The heating and cooling rates were both 10 °C / hour. The glass vial containing P3 was carefully broken, and P3 was removed and immersed in 100 mL of ultrapure water for dialysis purification for 10 days to remove unreacted monomers. The immersion solution was changed daily during this period. The successful synthesis of P3 was characterized by FT-IR and EDS elemental analysis (structure shown in the figure above, n = 13, degree of polymerization 15). Number average molecular weight = 13000 Da, polydispersity index (PDI) = 0.9. FT-IR: 3400 cm⁻¹ (OH), 2870 cm⁻¹ (CH₂), 1720 cm⁻¹, 1754 cm⁻¹ (C=O), 1100 cm⁻¹ (COC) cm⁻¹ -1 ; EDS: 78.69% (C), 21.31% (O).
[0094] (3) Synthesis of poly(ethylene glycol) dimethacrylate [PPEG, P4]: The polymerization method used was free radical random copolymerization. The initiator used was potassium persulfate (KPS, CAS No. 7727-21-1, Sigma-Aldrich Corp.), and the monomer used was polyethylene glycol dimethacrylate (PEGDMA, n=13, CAS No. 25852-47-5, Sigma-Aldrich Corp.). The same monomer mass as P2 was used. The specific synthesis steps were as follows: PEGDMA (40.0 mL, 60 mmol) was added to a 50 mL EP tube, and 30 mL of ultrapure water was added as a solvent. The mixture was dissolved by sonication and then shaken to mix. Subsequently, initiator KPS (0.4 g, 1.5 mmol) was added, and the mixture was shaken and mixed for 3 hours. The mixture was then poured into a 100 mL glass sample vial, sealed, and placed in an oven. For the first 12 hours, the temperature was maintained at 30 °C. Afterward, the temperature was increased to 80 °C, maintained for 6 hours, and then decreased to 30 °C, continuing this process for 2 days (including the initial 18 hours). The heating and cooling rates were both 10 °C / hour. The glass vial containing P4 was carefully broken, and P4 was removed and immersed in 100 mL of ultrapure water for dialyzing and purification for 10 days to remove unreacted monomers. The immersion solution was changed daily during this period. The successful synthesis of P4 was characterized by FT-IR and EDS elemental analysis (structure shown in the figure above, n = 13, degree of polymerization 19). Number average molecular weight = 16000 Da, polydispersity (PDI) = 0.3. FT-IR: 3059, 2341, 1754 cm⁻¹ -1 (Polyethylene glycol dimethacrylate carbonyl and backbone); EDS: 89.64% (C), 10.27% (O).
[0095] Example 8
[0096] Synthesis of Acrylate-3-aminophenylboronic acid
[0097]
[0098] Sodium bicarbonate (16.8 g, 25.0 mmol) was added to 50 mL of an ultrapure water and tetrahydrofuran (2:1 v / v) solution containing 3-aminophenylboronic acid (1.5 g, 1.0 mmol). The mixture was stirred at ambient temperature for 5 hours. Then, acryloyl chloride (203 μL, 2.5 mmol) was added to the mixture, and stirring was continued at ambient temperature for 24 hours. After evaporating the solvent, 50 mL of methanol was added, and the mixture was sonicated for 20 minutes. The mixture was centrifuged at 8000 rpm for 10 minutes, and the supernatant was collected, discarding the precipitate. The supernatant was then freeze-dried to obtain a white powder product (1.92 g, yield: 91.87%). The infrared, mass spectrometry, and NMR data are as follows: FT–IR: 3354, 3319, 2942, 1684, 1628, 1546, 1370, 1249, 845 cm⁻¹ -1 Q–TOF–MSm / z for(C9H 10 BNO3): Theoretical value [M+H] + 190.99; Actual value: 191.08. 1 H NMR (400MHz, DMSO-d6) δ (ppm): 7.88 (s, 4H, -ph), 6.40 (qd, J = 17.0, 5.9Hz, 2H, CH), 5.76 (dd, J = 9.8, 1.7Hz, 1H, CH), 1.34 (d, J = 45.9Hz, 2H, -OH).
[0099] Example 9
[0100] Synthesis of acrylated isothiocyanate fluorescein
[0101]
[0102] Allylamine hydrochloride (0.9 mg, 10 μM) and fluorescein isothiocyanate (3.9 mg, 10 μM) were dissolved in anhydrous DMF (4.5 mL). Triethylamine (35 μL, 0.3 mM) was added, and the mixture was stirred at room temperature for 48 h. After the reaction was complete, ultrapure water (4 mL) was added to the reaction solution. The pH was lowered to 3.0 using trifluoroacetic acid, and the solution was purified by reversed-phase HPLC using a C18 semi-preparative column (Huapu Scientific Instruments, 10X250xAqua) with a UV detector at 220 nm. Mobile phase A was ultrapure water with a volume concentration of 0.1% trifluoroacetic acid, and mobile phase B was methanol with a volume concentration of 0.1% trifluoroacetic acid. The gradient elution conditions were that the volume of mobile phase B increased from 10% to 90% within 30 minutes. The fraction corresponding to the peak at 23.8 min was collected, rotary evaporated under reduced pressure, and freeze-dried to obtain a yellow powder product (449.11 mg, yield: 85.4%). Infrared, mass spectrometry, and nuclear magnetic resonance data are as follows: FT–IR: 3504, 2850, 1750, 1630, 1400, 1349, 745 cm⁻¹ -1 Q–TOF–MSm / z for(C 24 H 20 N₂O₅S): Theoretical value [M+H] + 449.11; Actual value: 449.10. 1 H NMR (400MHz, CD3OD-d4) δ (ppm): 9.36 (s, 1H), 9.04 (s, 1H), 8.08 (d, J = 2.3Hz, 1H), 7.90 (dd, J = 8.2, 2.2Hz, 1H), 7.6 1(t,J=4.9Hz,1H),7.48(d,J=8.2Hz,1H),6.97(d,J=8.5Hz,1H),6.53(dd,J=8.5,2.1Hz,1H),6.35(d,J=2.2Hz,1H ),6.17–6.09(m,2H),5.90(tt,J=16.3,5.4Hz,1H),5.82(ddd,J=6.4,2.0,0.9Hz,1H),5.15(ddq,J=18.2,16.3,0. 8Hz, 2H), 5.07 (ddt, J=7.7, 6.6, 1.4Hz, 2H), 4.24 (ddt, J=5.8, 5.1, 1.1Hz, 2H), 4.01 (dtd, J=7.6, 4.9, 1.7Hz, 1H).
[0103] Example 10
[0104] Hydrogel functional polymers targeting CTCs (P5, P6, P7, and P8) were prepared using atom transfer radical polymerization.
[0105]
[0106] (1) Synthesis of poly(polyethylene glycol dimethacrylate-co-acrylamide 3-aminophenylboronic acid) [Poly(PPEG-co-3-(acrylamido)phenylboronic acid, PPEG-co-PBA, P5]: The polymerization method and initiator used were the same as in Example 7 (process and conditions). The monomer used was acrylamide 3-aminophenylboronic acid (PBA) (infrared, NMR and mass spectrometry characterization showed successful synthesis). The crosslinking agent used was polyethylene glycol dimethacrylate (PEGDMA, n=13, CAS No. 25852-47-5, Sigma-Aldrich). Corp). Taking y = 0.7 as an example, the specific synthesis steps are as follows: PEGDMA (30 mL, 40.0 mmol) and PBA (3 g, 20.0 mmol, added in two equal portions) are added sequentially to a 250 mL Erlenmeyer flask at a molar ratio of 2:1. Simultaneously, 100 mL of ultrapure water is added as a solvent. The mixture is sonicated and shaken to dissolve. Then, the initiator KPS (0.8 g, 3.0 mmol) is added, and the mixture is shaken to mix for 3 hours. The mixture is then poured into a 100 mL glass sample vial, the vial is sealed, and placed in an oven. Initially, the temperature is maintained at 30°C for the first 12 hours. The temperature was then raised to 80°C, maintained for 6 hours, and then lowered to 30°C, a process repeated for two days (including the initial 18 hours), with a heating / cooling rate of 10°C / hour. The glass vial containing P5 was carefully broken, and the P5 was removed and immersed in 100 mL of ultrapure water for dialyzing and purification for 10 days to remove unreacted monomers, with the immersion solution changed daily. Characterization using infrared spectroscopy and scanning electron microscopy (SEM) elemental analysis confirmed the successful synthesis of P5 (structure shown in the figure above, y = 0.7). Number-average molecular weight = 87000 Da, polydispersity (PDI) = 1.4. FT-IR: 2769 cm⁻¹ -1 (PEGDMA ester group), 1586, 1500cm -1 (Benzene ring); EDS: 52.81% (C), 11.13% (N), 25.63% (O), 9.56% (B).
[0107] (2) Synthesis of poly(polyethylene glycol dimethacrylate-co-flexible two-arm phenylboronic acid) [Poly(PPEG-co-DPBA), PPEG-co-DPBA, P6]: The polymerization method (random copolymerization) and initiator used were the same as in Example 7 (process and conditions), the reactive monomer used was flexible two-arm phenylboronic acid (DPBA) (infrared, NMR and mass spectrometry characterization showed successful synthesis), and the crosslinking agent used was polyethylene glycol dimethacrylate (PEGDMA, n=13, CAS No.25852-47-5, Sigma-AldrichCorp). Taking y = 0.7 as an example, the specific synthesis steps are as follows: PEGDMA (30 mL, 40.0 mmol) and DPBA (12 g, 20.0 mmol, added in two equal portions) are added sequentially to a 250 mL Erlenmeyer flask at a molar ratio of 2:1. Simultaneously, 100 mL of ultrapure water is added as a solvent. The mixture is sonicated and shaken to dissolve and mix thoroughly. Then, the initiator KPS (0.8 g, 3.0 mmol) is added, and the mixture is shaken and mixed for 3 hours. The mixture is then poured into a 100 mL glass sample vial, sealed, and placed in an oven. For the first 12 hours, the temperature is maintained at 30°C. Afterward, the temperature is increased to 80°C, maintained for 6 hours, and then decreased to 30°C, continuing this process for 2 days (including the initial 18 hours). The heating and cooling rates are both 10°C / hour. The glass vial containing P6 is carefully broken, and P6 is removed and immersed in 100 mL of ultrapure water for dialyzing purification for 10 days to remove unreacted monomers. The ultrapure water solution is changed daily during this period. The successful synthesis of P6 was confirmed by elemental analysis using infrared spectroscopy and scanning electron microscopy (structure shown in the figure above, y = 0.7). Number-average molecular weight = 103400 Da, polydispersity (PDI) = 1.2. FT-IR: 3500 cm⁻¹ -1 (hydroxyl), 3350cm -1 (Nitrogen and hydrogen), 2853cm -1 (PEGDMA ester group), 1580, 1450, 700 cm -1 (Benzene ring), 1230cm -1 (Boron hydroxyl); EDS: 60.12% (C), 23.63% (N), 11.51% (O), 4.74% (B).
[0108] (3) Synthesis of poly(polyethylene glycol dimethacrylate-co-rigid two-arm phenylboronic acid) [Poly(PPEG-co-DPBH), PPEG-co-DPBH, P7]: The polymerization method (random copolymerization) and initiator used were the same as in Example 7 (process and conditions), the monomer used was rigid two-arm phenylboronic acid (DPBH) (infrared, NMR and mass spectrometry characterization showed successful synthesis), and the crosslinking agent used was polyethylene glycol dimethacrylate (PEGDMA, n=13, CAS No.25852-47-5, Sigma-AldrichCorp). Taking y = 0.7 as an example, the specific synthesis steps are as follows: PEGDMA (30 mL, 40.0 mmol) and DPBH (11 g, 20.0 mmol, added in two equal portions) are added sequentially to a 250 mL Erlenmeyer flask at a molar ratio of 2:1. Simultaneously, 100 mL of ultrapure water is added as a solvent. The mixture is sonicated and shaken to dissolve and mix thoroughly. Then, the initiator KPS (0.8 g, 3.0 mmol) is added, and the mixture is shaken and mixed for 3 hours. The mixture is then poured into a 100 mL glass sample vial, sealed, and placed in an oven. For the first 12 hours, the temperature is maintained at 30°C. Afterward, the temperature is increased to 80°C, maintained for 6 hours, and then decreased to 30°C, continuing this process for 2 days (including the initial 18 hours). The heating and cooling rates are both 10°C / hour. The glass vial containing P7 is carefully broken, and the P7 is removed and immersed in 100 mL of ultrapure water for dialyzing purification for 10 days to remove unreacted monomers. The immersion solution is changed daily during this period. The successful synthesis of P7 was confirmed by elemental analysis using infrared spectroscopy and scanning electron microscopy (structure shown in the figure above, y = 0.7). Number-average molecular weight = 98400 Da, polydispersity (PDI) = 1.3. FT-IR: 3480 cm⁻¹ -1 (hydroxyl), 3320cm -1 (Nitrogen and Hydrogen) 2853cm -1 (PEGDMA ester group), 1583, 1460, 700cm -1 (Benzene ring), 1250cm -1 (Boron hydroxyl); EDS: 54.47% (C), 26.83% (N), 12.66% (O), 6.04% (B).
[0109] (4) Synthesis of fluorescein isothiocyanate labeled poly(polyethylene glycol dimethacrylate-co-flexible two-arm phenylboronic acid) [FITC-Poly(PPEG-co-DPBA), FITC-PPEG-co-DPBA, P8]: The polymerization method (random copolymerization) and initiator used were the same as in Example 7 (process and conditions). The reactive monomers used were flexible two-arm phenylboronic acid (DPBA) and acrylated fluorescein isothiocyanate (infrared, NMR and mass spectrometry characterization showed successful synthesis). The crosslinking agent used was polyethylene glycol dimethacrylate (PEGDMA, n=13, CAS No.25852-47-5, Sigma-Aldrich Corp.). Taking y = 0.7 as an example, the specific synthesis steps are as follows: PEGDMA (30 mL, 40.0 mmol), acrylated fluorescein isothiocyanate (0.5 g, 1.0 mmol), and DPBA (12 g, 20.0 mmol, added in two equal portions) are added sequentially in a 250 mL Erlenmeyer flask with a molar ratio of 2:0.05:1. 100 mL of ultrapure water is added as a solvent. The mixture is sonicated and shaken to dissolve and mix. Then, the initiator KPS (0.8 g, 3.0 mmol) is added and shaken to mix for 3 hours. The mixture is then poured into a 100 mL glass sample vial, the vial is sealed, and the vial is placed in an oven. The oven is initially kept at 30 °C for 12 hours, then the temperature is increased to 80 °C, maintained for 6 hours, and then decreased to 30 °C. This process is repeated for 2 days (including the first 18 hours), with a heating and cooling rate of 10 °C / hour. The glass vial containing P8 was carefully broken, and the P8 was removed and immersed in 100 mL of ultrapure water for dialysis purification for 10 days to remove unreacted monomers. The immersion solution was changed daily during this period. Characterization by infrared spectroscopy and scanning electron microscopy (SEM) elemental analysis confirmed the successful synthesis of P8 (structure shown in the figure above, y = 0.7). Number-average molecular weight = 108400 Da, polydispersity (PDI) = 1.4. FT-IR: 3500–3300 cm⁻¹ -1 (fluorescein isothiocyanate hydroxyl group), 2550cm -1 (Nitrogen and hydrogen), 2853cm -1 (PEGDMA ester group), 1635cm -1 (Alkenyl), 1580, 1450, 750cm -1 (Benzene ring), 1250cm -1 (ether group), 1230cm -1 (Boron hydroxyl); EDS: 60.62% (C), 23.98% (N), 12.06% (O), 3.11% (B), 0.23% (S).
[0110] Example 11
[0111] Anti-swelling property test of P3, P4 and P6 hydrogels.
[0112] Six samples (each weighing 1 g) of P3, P4, and P6 hydrogels were immersed in 10 mL of PBS. The samples were removed at 0.08, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.2, 1.3, 1.5, 1.7, 1.8, 2.0, 2.3, 2.5, 3.0, 3.5, 4.0, 4.5, 5.0, 6.0, 7.0, 8.0, 9.0, 10.0, 11.0, 13.0, 19.0, 25, 37, and 50 h, dried, and weighed. The weight at 0 h is calculated as W. d The weight for the remaining time is W. t Using the formula: SR(%) = (W) t -W d )×100 / W d Calculate and plot the changes in various hydrogels. Common hydrogel frameworks, such as poly(polyethylene glycol methyl ether methacrylate) (PPM), have been widely used in controlled drug release, soft tissue wound healing, bioelectronics, tissue adhesives, and cell sorting. P2 hydrogels were prepared via atom transfer radical polymerization; however, P2 hydrogels are unstable and prone to collapse. To improve their stability, PEGDMA, with its flexible structure, good antifouling properties, and tunable molecular weight, was introduced as a chemical crosslinking agent. The resulting P3 hydrogel significantly enhanced the stability of the P2 hydrogel network. However, after soaking in PBS for 50 hours, [the following text appears to be incomplete and requires further context: "from..."] Figure 7 As shown in Figure a, hydrogel P3 exhibits swelling, with a swelling rate exceeding 200%. In stark contrast, hydrogel P4 demonstrates anti-swelling properties, with a swelling rate of only 19% after 50 hours, indicating its potential as a framework for cell imprinting materials. Further copolymerization with flexible double-arm phenylboronic acid yields hydrogel P6, which exhibits an even lower swelling rate.
[0113] In the T2 relaxation of LF-NMR, relaxation peaks at different positions represent different states of binding of H nuclei, thus characterizing their different mobility. H nuclei with a higher degree of binding have poorer mobility and shorter relaxation times; conversely, relatively free H nuclei with a lower degree of binding have better mobility, higher degrees of freedom, and longer relaxation times. Based on this property, we can determine the state of water molecules inside the gel, and further, we can use peak area to indicate the water content. The specific operation is as follows: First, calibrate the LF-NMR (Suzhou Newmai Technology). Select the instrument default for the magnet probe; select Q-FID for the sequence name, with default parameters; place the standard sample (standard oil sample); click "single sampling," wait 10 seconds, and click "stop sampling"; click "find center frequency (SF+01)" until the FID curve no longer shows regular oscillations; click "pulse width," and the software automatically finds 90° and 180° pulse widths until a peak and a trough appear, indicating that the pulse width has been correctly found. Then, 1g of P3, P4, and P6 hydrogels (5cm in diameter and 5cm in height) were sequentially placed into the magnetic field cavity. The CPMG sequence was selected, the sequence name was entered, appropriate parameters were set, and sampling was clicked to determine the T2 relaxation time. The states of different water molecules were then obtained through inversion. For example... Figure 7 As shown in b, hydrogels P3, P4, and P6 were immersed in 50 mL of phosphate buffer solution (PBS = 10 mM, pH = 7.4, the same below) for 7 days, then removed and placed in a magnetic field chamber for testing. The T2 component peaks located at 0.1–3, 70–200, and 800–2200 ms correspond to bound water, fixed water, and free water, respectively. Compared with bound water (T1) and fixed water (T2), the change in free water (T3) in the polymer network during hydrogel swelling was more significant. After immersion in PBS for 50 h, the integral areas of the T3 peaks of P3, P4, and P6 hydrogels were 978, 324, and 163, respectively. Figure 7 b) further illustrates the excellent anti-swelling properties of P6 hydrogel.
[0114] P3 hydrogels are water-compatible hydrophilic polymers. The permeation of water molecules causes the polymer chains to swell, ultimately leading to changes in the macroscopic volume of these hydrogels. Crosslinking of PEGDMA shortens the distance between adjacent polymer chains, constructing an interconnected, dense, and stable three-dimensional network. Figure 7 c). An increase in the PEGDMA ratio was associated with improved anti-swelling ability. To examine the surface morphology of P3, P4, and P6 hydrogels before and after immersion in PBS, we used scanning electron microscopy. Figure 7 As shown in df, after soaking in PBS for 50 h, significant morphological changes were observed in hydrogel P3, characterized by the appearance of many large and irregular pores on the surface. Figure 7d). Quantitative calculations using ImageJ software showed its porosity to be 50.2%, with an average pore size of 47 ± 10.0 μm. In contrast, hydrogel P4 ( Figure 7 e) It maintained a dense surface, characterized by long, thick, and interconnected polymer fibers. After copolymerization with DPBA, the surface morphology of hydrogel P6 did not change significantly. Figure 7 f) These phenomena can explain why hydrogel P6 can resist swelling.
[0115] Example 12
[0116] In-situ temperature-variable infrared spectroscopy was used to analyze the relationship between the water content and the hydrogel network in a smart responsive hydrogel.
[0117] The water absorption and swelling of hydrogels rely on a three-dimensional cross-linked network that provides expansion space. Hydrophilic groups in the polymer chains bind to water, increasing internal osmotic pressure and driving water permeation until the osmotic pressure and network elasticity reach equilibrium. The gaps in the network accommodate water, while the cross-linking points maintain structural integrity, preventing unlimited expansion and dissolution. Depending on the application, hydrogels can be classified as swellable or non-swellable, and their design is influenced by cross-linking density, monomer hydrophilicity / hydrophobicity, charge properties, and environmental factors. The core principle lies in balancing elastic recoil and the interaction between the polymer and water.
[0118] Swellable hydrogels achieve high water absorption using hydrophilic monomers (e.g., hydroxyl, carboxyl groups) and low-crosslinking networks, further enhanced by electrostatic repulsion through ionizable groups. However, swelling can impair the specificity and mechanical strength of cell-imprinted polymers. Anti-swelling designs minimize polymer-water interactions and enhance elasticity. While hydrophobic monomers, dual-network structures, and ionic complexes can suppress swelling, they are unsuitable for biomedical applications requiring high performance in physiological environments, where hydrophilicity is crucial and functional group density must be maximized. Increasing crosslink density enhances elastic recovery but increases the risk of brittleness. Our PEGDMA-based design combines moderate hydrophilicity (ether oxygen) with dense crosslinking (terminal double bonds) to achieve flexibility. The addition of DPBA units further reduces swelling through hydrophobic phenyl and boron bonds.
[0119] To investigate the mechanism of polymer expansion, in-situ FT-IR spectra were recorded at different temperatures. This technique is a powerful tool for monitoring changes in intramolecular covalent and non-covalent bonds. P2, P4, and P6 hydrogels were ground into powder using a mortar and pestle, and then placed into 1.5 mm thick crucibles. These crucibles were placed in the circular slot of an in-situ temperature-variable infrared instrument (Thermofisher, Nicolet 6700). A gradient temperature increase range was set, and the temperature was uniformly increased from 30 °C to 90 °C over 2 hours. Infrared spectral data were recorded at 30, 35, 40, 45, 50, 60, 70, 80, and 90 °C. Two spectral regions were subsequently analyzed, one ranging from 3400 to 3700 cm⁻¹. -1 Corresponding to the OH stretching vibration, another range is from 1620 to 1680 cm. -1 This corresponds to the in-plane shear vibrations of hydrophilic groups (e.g., hydroxyl, carboxyl, amide). As the temperature increases from 30°C to 90°C, water molecules evaporate and separate from the hydrogel, leading to polymer network reconstruction. Figure 8 a). For P2 hydrogels, significant changes in both intensity and wavenumber of the vibrational peaks were observed, indicating a strong influence of water on the polymer network. Figure 8 b and 8e). In contrast, the corresponding changes in the P4 hydrogel were significantly smaller, which can be reasonably attributed to its strong chemical cross-linking (b and 8e). Figure 8 c and f). The subtle changes observed in the FT-IR spectrum of the P6 hydrogel were recorded by temperature-correlated FT-IR analysis, further validating this property. Figure 8 d and 8g). The anti-swelling properties enhanced by P6 hydrogel are mainly due to two factors: (1) the dynamic hydrogen bonds between the B-OH groups in DPBA and the abundant O atoms in P4 hydrogel; (2) the flexible double-arm structure of DPBA, which facilitates more effective crosslinking. These synergistic effects result in a tighter polymer network.
[0120] Example 13
[0121] Preparation and characterization of microstructure of smart responsive hydrogels P6+ and P8+ cell imprints
[0122] 1. Preparation of P6+ cell-imprinted hydrogels
[0123] First 4×10 6The previous night, SMMC-7721 cells were placed in a 100mm inner diameter, 100mm height cell culture dish and 10mL of cell culture medium (89% Dulbecco's modified eagle medium, DMEM (Gibco), 10% Fetal bovine serum, FBS (ExCell Bio), and 1% penicillin-streptomycin, 100X (Beyotime; the cell culture mediums described below have the same composition) were added. The cells were cultured until the morning of the following day (12 hours in total). The culture medium was removed, and the cells were washed three times with PBS solution (PBS = 10mM, pH = 7.4, the same below). 2mL of pre-prepared, membrane-passed (0.22μm) paraformaldehyde solution (4% by mass) was added, and the cells were fixed at 37℃ for 5min. The fixative was removed, and the cells were washed three times with PBS solution (PBS = 10mM, pH = 7.4, the same below). Next, PEGDMA (30 mL, 40.0 mmol) and DPBA (12 g, 20.0 mmol, added in two equal portions) were added sequentially to a 250 mL Erlenmeyer flask at a molar ratio of 2:1. 100 mL of ultrapure water was added as a solvent, and the mixture was sonicated and vortexed. Then, the initiator KPS (0.8 g, 3.0 mmol) was added, and the mixture was vortexed for 3 hours. Five mL of the solution was then transferred to a cell culture dish containing immobilized cells and shaken at 300 rpm for 3 hours to allow the functional monomers in the solution to seek target molecules on the cell surface. The culture dish was then transferred to an oven and kept at 30 °C for the first 12 hours. The temperature was then increased to 80 °C, held for 6 hours, and then decreased to 30 °C, repeated for 2 days (including the initial 18 hours), with a heating / cooling rate of 10 °C / hour. This yielded a hydrogel P6-cell with cell imprints and functional groups. The P6-cell hydrogel was rinsed with ultrapure water. Ultrapure water was slowly added from the edge of the cell culture dish to detach the P6-cell hydrogel from the dish. The P6-cell hydrogel was then removed and immersed in 10 mL of ultrapure water for dialyzing purification for 10 days, changing the immersion solution daily. Afterward, the gel was removed and immersed in 10 mL of trypsin solution (Trypsin & EDTA solution: 0.25% Trypsin & 0.02% EDTA; pH ~8.0 (VivaCell)). After 4 hours, the gel was rinsed three times with 5 mL of phosphate-buffered saline (PBS = 10 mM, pH = 7.4) and stored in 10 mL of PBS solution (PBS = 10 mM, pH = 7.4). This process was to remove cell templates, unreacted monomers, and KPS residues, thereby preparing the intelligent responsive molecularly imprinted hydrogel P6+ carrying functional monomers and cell micromorphology. Scanning electron microscopy revealed… Figure 9 The indentation shown in image a represents the microscopic morphology of the cellular imprint. (Atomic force microscope image) Figure 9 (b) The spatial structure of the imprinted cavity is clearly shown, conforming to the shape and filamentous pseudopodia of the original cells. It is important to consider that CTCs typically exhibit a spherical appearance when suspended, but their morphology becomes polygonal after adhering to the culture material surface, matching the prepared cavity. Figure 9 Figures a and 9b show that the P6+ imprinted hydrogel maintains the morphological characteristics of the adherent cells. In practical applications involving blood, CTCs require approximately 3 hours of sufficient contact time to adapt and settle into the imprint cavity.
[0124] 2. Preparation of P8+ cell-imprinted hydrogels
[0125] To visualize the actual morphology of CTCs in the blotted hydrogel, SMMC-7721 cells were used as a template. Acrylamide isothiocyanate fluorescein was copolymerized with PEGDMA and DPBA to prepare a fluorescein-labeled polymer hydrogel P8 that emits bright green fluorescence. The specific preparation procedure was as follows: PEGDMA (30 mL, 40.0 mmol), acrylamide isothiocyanate fluorescein (0.5 g, 1.0 mmol), and DPBA (12 g, 20.0 mmol, added in two equal portions) were added sequentially to a 250 mL Erlenmeyer flask in a molar ratio of 2:0.05:1. 100 mL of ultrapure water was added as a solvent, and the mixture was sonicated and shaken to dissolve and mix thoroughly. Then, the initiator KPS (0.8 g, 3.0 mmol) was added, and the mixture was shaken for 3 hours. 5 mL of the solution was then transferred to a cell culture dish containing immobilized cells and shaken at 300 rpm for 3 hours to allow the functional monomers in the solution to seek target molecules on the cell surface. Subsequently, the culture dishes were transferred to an oven and initially maintained at 30°C for 12 hours. The temperature was then increased to 80°C, maintained for 6 hours, and then decreased to 30°C, repeating this process for two days (including the initial 18 hours). The heating and cooling rates were both 10°C / hour. This yielded P8-cell hydrogels with cell imprints and functional groups. The P8-cell hydrogels were rinsed with ultrapure water, and ultrapure water was slowly added from the inner edge of the cell culture dish to detach the P8-cell hydrogels. The P8-cell hydrogels were then immersed in 10 mL of ultrapure water for dialyzing and purification for 10 days, with the immersion solution changed daily during this period. The gel was then removed and immersed in 10 mL of trypsin EDTA solution (0.25% Trypsin & 0.02% EDTA; pH ~8.0 (Viva Cell)). After 4 hours, the gel was rinsed three times with 5 mL of phosphate buffered saline (PBS = 10 mM, pH = 7.4) and stored in 10 mL of PBS solution (PBS = 10 mM, pH = 7.4). This process was to remove the cell template, unreacted monomers, and KPS residues, thereby preparing the P8+ smart responsive molecularly imprinted hydrogel carrying functional monomers and cell micromorphology.
[0126] SMMC-7721 cells were then captured using a P8+ hydrogel: after 3 hours of culture, the hydrogel surface was washed with PBS to remove unbound cells. The captured cells were then stained with fluorescent dyes: Dil (red) labeled the cell membrane, and DAPI (blue) labeled the DNA for nucleus identification. Using a ZEISS LSM 980 with Airyscan 2, cells located within the lumen were selected for three-dimensional (3D) imaging from various angles to study the morphology of CTCs within the blot pits. Figure 9As shown in the CLSM scan slice in c, cells are positioned in 3D space along the X (32 μm), Y (32 μm), and Z (16 μm) axes, surrounded by a P8+ hydrogel labeled with fluorescein isothiocyanate. These spatial dimensions are consistent with the characteristics of a single-cell template, indicating a close interaction between the imprinted cavity and the cell surface. Furthermore, 3D reconstruction using CLSM was performed to observe the nanoscale and microscale structures of the imprinted cavity within the hydrogel. The rough 3D structure is very similar to the surface morphology of filopodia and the size of SMMC-7721 cells, ensuring precise cell capture. Figure 9 d). These findings demonstrate that SMMC-7721 cells can be easily placed into pre-formed wells in the hydrogel. Micrometer-scale cell size, nanoscale filamentous pseudopodia, and surface glycan recognition are crucial for the hierarchical interface of P6+ hydrogels in capturing target cells.
[0127] Application Examples
[0128] Example 14: Blood compatibility of smart responsive hydrogel P6
[0129] 1. Blood collection
[0130] All blood sample collection was conducted in strict accordance with relevant national laws, regulations, and industry standards (GB / T16886.4-2003 / ISO10993-4:2002, jointly issued by the General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China and the Standardization Administration of the People's Republic of China), and was completed at the Second Affiliated Hospital of Dalian Medical University (Dalian, China). This study has been reviewed and approved by the Ethics Committee of the Second Affiliated Hospital of Dalian Medical University (Ethics Approval No.: 2023141). Sample collection and experimental protocols were conducted in accordance with the ethical guidelines of the Declaration of Helsinki, and participating patients were informed and their consent forms were obtained. Furthermore, this study fully complied with the relevant regulations of the Institutional Review Board (IRB) to ensure that the use of human blood samples met ethical requirements and legal norms.
[0131] Fresh peripheral blood samples (100 mL) were collected from healthy volunteers using aseptic collection tubes (purple). Collected blood samples were immediately stored at 4°C and the experiments were completed within 2 hours. Blood samples were allocated according to the experimental design: 30 mL for coagulation and 36 mL for hemolysis. Red blood cell separation was performed by centrifugation at 4000 rpm for 15 min at 4°C. All experimental consumables were sterilized by high-temperature moist heat treatment and dried before use to ensure sterile conditions.
[0132] 2. Coagulation test
[0133] We filled centrifuge tubes containing small, uniform P4 and P6 hydrogels (20 mg each, 6 portions) with 1 mL of anticoagulated whole blood and incubated them at 37°C for 3 min. Then, we added CaCl2 (30 μL, 0.2 M) solution to improve coagulation. The centrifuge tubes were tilted in a 37°C water bath every 15 s for observation. The time it took for blood to stop flowing was recorded as the clotting time. The average clotting time of the P4 hydrogel was 2771 s, shorter than the 3378 s of the blank control group. Notably, the clotting time of the P6 hydrogel was 3233 s, closer to the control value, indicating no significant effect on blood coagulation. Figure 10 a).
[0134] 3. Hemolysis test
[0135] The hemolysis rate reflects the degree of damage to the cell membrane integrity when the material comes into contact with RBCs. The anti-hemolysis performance of the material can be evaluated by measuring the amount of hemoglobin released in the solution. Generally, the lower the hemolysis rate, the less damage the material causes to RBCs and the higher the blood compatibility. The specific operation is as follows: (1) First, rinse all instruments with water, soak them in dilute hydrochloric acid for one day, and then rinse them with water. After that, soak them in pure water for half an hour and then soak them in ultrapure water for about half an hour. Then put the instruments into a high-pressure steam sterilizer and sterilize them at 121°C for 20 minutes. Take them out for use. (2) Add 0.1 mL of red blood cell solution to centrifuge tubes containing P4 and P6 hydrogels respectively, and then add 2 mL of phosphate buffer solution (PBS, pH 7.4) respectively. Use only ultrapure water as a positive control and only PBS as a blank control group. After incubating the sample in a 37°C water bath for 2.5 h, centrifuge at 8000 rpm for 5 min at 4°C and measure the absorbance (A) of the supernatant at 545 nm. The hemolysis rate of the samples was calculated using the formula: Hemolysis rate (%) = [(A-A0) / (A1-A0)] × 100, where A is the experimental group; A0 is the blank control; and A1 is the positive control. The experimental results showed that after 2.5 hours of water bath incubation, the positive control group (ultrapure water) showed significant hemolysis, and the solution turned red; while in the experimental groups, after centrifugation, red blood cells were deposited at the bottom of the tubes, and no significant hemolysis was observed. Quantitative analysis of the characteristic absorption peaks of hemoglobin in each group at 545 nm showed (…). Figure 10 b) The hemolysis rate of all experimental groups was less than 5%, which meets the requirements of blood compatibility for biomedical materials.
[0136] Example 15: Evaluation of CTC capture, release and adaptability of smart responsive hydrogel P6+.
[0137] 1. Capture efficiency of P6+ hydrogel on SMMC-7721 cells
[0138] SMMC-7721 cells (10 5 104 10 3 10 2 10) A 1 ml blood sample (from a healthy patient undergoing a physical examination) with a doping density of 1) was dropped onto a P6+ hydrogel (area: 14 cm²). 2 (Height: 0.7cm) surface, cultured in a cell culture incubator for 3 hours. For these cells doped with SMMC-7721 (10 5 and 10 4 After incubation with the P6+ hydrogel, wash the gel with 1 mL of PBS at 37°C, and collect weakly adsorbed cells by centrifugation at 1000 rpm. The capture efficiency is defined and calculated using the following formula: Capture efficiency (%) = (1 - cell...) weak / cell total )×100. Where cell weak and cell total These represent the number of weakly adsorbed cells and the total number of SMMC-7721 cells counted on the P6+ hydrogel, respectively.
[0139] For those doped with SMMC-7721(10) 3 and 10 2 The hydrogel was stained with DAPI (2 mL, 2 μg / mL). The number of captured cells was then determined by observation and counting using a fluorescence microscope. The capture efficiency was calculated as follows: Capture efficiency (%) = (Number of captured cells / Total number of cells) × 100. Wherein the number of captured cells and the total number of cells are the number of SMMC-7721 cells captured and incorporated into the hydrogel, respectively.
[0140] From the experimental results Figure 11As shown in Figure 1, the P6+ hydrogel exhibited high capture efficiency for SMMC-7721 cells, achieving a capture rate of 96±2.1% even with only 100 cells. When only 10 cells were evaluated, the capture efficiency remained stable at 94±2.0%. This capture capability is particularly important for capturing CTCs in real-world samples, as only about 1-2 CTCs are typically present in 1 mL of blood. The combination of Western blotting technology and the high selectivity of DPBA for bibranched sialic acid polysaccharides on the CTC surface contributed to this excellent capture efficiency. Without Western blotting, the capture efficiency of the P6 hydrogel for 100 or 10 cells was only 61±2.0% and 59±1.5%, respectively. Furthermore, a comparison of the performance of P6 and P5 hydrogels revealed that the capture efficiency of the P5 hydrogel decreased with decreasing cell numbers, with a capture efficiency of 77±0.4% for 100 cells and 54±2.3% for 10 cells. These results indicate that DPBA has a higher binding affinity for SMMC-7721 cells compared to PBA alone. To verify the role of the flexible ethylenediamine arm in DPBA, we tested the capture performance of the P7+ hydrogel. When evaluating 10 cells, the capture efficiency of this rigid material was only 73 ± 2.4%, lower than that of the P6+ hydrogel. These findings suggest that the P6+ hydrogel is a suitable material for specifically capturing SMMC-7721 cells.
[0141] 2. Release activity of P6+ hydrogel on SMMC-7721 cells
[0142] Stable and highly active release of captured cells is essential for the use of CTC-captured materials in single-cell analysis. We first treated 10 cells with 50 μL of trypsin-EDTA solution. 5 The surface of the hydrogel after seeding SMMC-7721 cells and washing with PBS was treated. 0.2 mL of pre-warmed (37°C) trypsin solution [Trypsin EDTA solution: 0.1–0.5% Trypsin & 0.005%–0.05% EDTA; pH–8.0 (Viva Cell)] was added, and the cells were digested for 1 minute. Immediately afterward, 1 mL of pre-warmed (37°C) cell culture medium was added. Cells adhering to the hydrogel surface were removed by pipetting the culture medium. The solution was collected and centrifuged at 1000 rpm for 3 minutes. The supernatant was discarded, and the cell pellet was resuspended in 2 mL of cell culture medium. The pellet was then placed in a 35 mm culture dish, and 6 samples were treated simultaneously. Cells were digested with trypsin on days 2, 4, 8, 10, and 12, seeded in 96-well plates, and cell viability was measured. 10 cells not added to the P6+ hydrogel surface... 5SMMC-7721 cells were used as a control group, and the same procedure was performed. The specific procedure for cell viability testing was as follows: Cells were seeded at a density of 5000 cells / well in 96-well plates and incubated at 37°C with 5% CO2 for 24 h. Then, the culture medium and samples were discarded, and 100 μL of methylthiazolyl diphenyl-tetrazolium bromide (MTT) solution (0.500 mg / mL) was added to each well and incubated for 4 h. Then, the MTT solution was discarded, and 100 μL of dimethyl sulfoxide was added to each well to dissolve formazan crystals. The 96-well plate was placed on a Multiskan FC, and the OD value was read at 570 nm. Cell viability for each sample was calculated using the following formula: Cell viability (%) = OD sample / OD control ×100. Where OD sample The absorbance value, OD, represents the value of the released and recultured cells. control These represent cells that are growing normally. From Figure 11 b shows that the released cells initially had the same density as normal SMMC-7721 cells and exhibited similar activity to the control group, indicating that the capture and release operation did not affect the cells.
[0143] 3. Adaptation of P6 hydrogel to SMMC-7721 cells
[0144] Key factors in determining whether a prepared material is suitable for biodiagnostic devices are its processability and flexibility. P6 hydrogel can be squeezed with a finger and returns to its original shape after the external force is removed, such as... Figure 11 As shown in c, this property also led us to focus on its elastic modulus, because the interaction between materials and cells is a key determinant of therapeutic efficacy and potential applications. Through relevant literature, we know that the extracellular matrix (ECM) plays an important role in influencing tissue behavior by mechanically transmitting physical signals to cells. The modulus of CTC is 6.2 kPa, becoming stronger in the lesion area (…). Figure 11 d).
[0145] We used a rheometer (TA DHR3) to test the elastic modulus of the P6 hydrogel. The rheometer had a parallel plate (25 mm in diameter) with a gap maintained at 3.0 mm. The strain amplitude was scanned from 0.1 to 1000% at a constant angular frequency of 10 rad / s to provide the linear viscoelastic range of the hydrogel. Then, frequency scans were performed on the hydrogel samples, with the angular frequency varying from 1 to 100 rad / s at 1% of a fixed strain. The elastic modulus test showed that the modulus of the P6 hydrogel was 7 kPa. Figure 11d) The properties of P6 hydrogel are very similar to those of CTCs derived from cancer tissue, thus facilitating in vitro interaction with CTCs. In contrast, P4 hydrogel has a higher modulus of 14 kPa. These results, combined with the low swelling properties and good compressibility of P6 hydrogel, and the efficient trapping ability and excellent blood compatibility of P6+ hydrogel, make P6+ a potential candidate material for enriching CTCs and for the diagnosis of liver cancer.
Claims
1. Flexible double-arm phenylboronic acid, characterized in that: Its structure is as follows:
2. A method for preparing the flexible double-arm phenylboronic acid according to claim 1, characterized in that: (1) Synthesis of 3,5-di(ethoxycarbonyl)-1-(hex-5-en-1-yl)pyridine: Diethyl pyridine-3,5-dicarboxylic acid (0.1-5 g) and 6-bromo-1-hexene (0.1-5 g) were dissolved in anhydrous DMF at 50-200 °C under an inert atmosphere and stirred for 3-24 h. After cooling to 0-100 °C, the solution was purified by reversed-phase HPLC using a C18 semi-preparative column. Mobile phase A was water with a volume concentration of 0.05-0.5% trifluoroacetic acid, and mobile phase B was methanol with a volume concentration of 0.05-0.5% trifluoroacetic acid. The gradient elution conditions were such that the volume content of mobile phase B increased from 5-10% to 85-95% within 3-80 minutes. The product fractions corresponding to the product fractions within 10-36 minutes were collected, dried, and 3,5-di(ethoxycarbonyl)-1-(hex-5-en-1-yl)pyridine was obtained. (2) Synthesis of 3,5-di((2-aminoethyl)carbamoyl)-1-(hex-5-en-1-yl)pyridine: 3,5-di(ethoxycarbonyl)-1-(hex-5-en-1-yl)pyridine (0.1-15 g) and ethylenediamine (1.0-20 g) were dissolved in 10-200 ml of anhydrous methanol at 0-25 °C and stirred for 3-24 h. The residue of ethylenediamine was removed by methanol extraction to finally obtain 3,5-di((2-aminoethyl)carbamoyl)-1-(hex-5-en-1-yl)pyridine; (3) Synthesis of flexible double-arm phenylboronic acid: 2-Formylphenylboronic acid (0.1-5 g) was dissolved in anhydrous methanol (1-100 mL) at 0-100 °C under an inert atmosphere to obtain a reaction mixture; anhydrous methanol (1-100 mL) containing 0.1-50 g of 3,5-bis((2-aminoethyl)carbamoyl)-1-(hex-5-en-1-yl)pyridine was added to the reaction mixture, and the mixture was stirred at 0-80 °C for 1-90 min, and then stirred at room temperature for 2-10 h; the mixture was then cooled again. The temperature was lowered to 0–60°C, and NaBH4 (0.2–15 g) was added. The mixture was then stirred at room temperature for 0.1–8 h. The reaction solution was then rotary evaporated under reduced pressure to 1 / 3–1 / 8 of its original volume. Deionized water (1–50 mL, 0–50°C) and saturated NaHCO3 aqueous solution (5–80 mL) were added to the above concentrated solution, and the mixture was stirred for 10–100 min. The reaction solution was extracted with dichloromethane (10–100 mL), and the organic phase was dried with sodium sulfate. After drying, the flexible double-arm phenylboronic acid DPBA was finally obtained.
3. A silicon sphere P1 grafted with flexible double-arm phenylboronic acid as described in claim 1, characterized in that: Flexible double-arm phenylboronic acid modified silica spheres (DPBA@SiO2) are synthesized by grafting a silane coupling agent onto the surface and then carrying out a sulfur bond chemical reaction. Specifically, 3-mercaptopropyltrimethoxysilane is grafted onto the surface of silica microspheres to expose thiol groups. Subsequently, DPBA is introduced through a sulfur bond chemical reaction between the thiol and alkenyl groups in DPBA to obtain DPBA@SiO2.
4. A method for preparing the flexible double-arm phenylboronic acid-grafted silicon sphere P1 according to claim 3, characterized in that: (1) Synthesis of mercaptopropyl modified silica (SH@SiO2): 1.0 g of silica microspheres was suspended in HNO3 (1%–15% by mass, 1–15 mL) for 0.1–50 h; then the hydroxylated silica microspheres were separated by centrifugation at 300–6000 rpm for 5–50 min, washed and dried; the hydroxylated silica microspheres (1–500 mg) were dispersed in 1–15 mL of anhydrous toluene and 0.1–0.5 mL of 3-mercaptopropyltrimethoxysilane, and the reaction mixture was refluxed at 50–110 °C for 2–60 h. The resulting silica microspheres (SH@SiO2) were separated by centrifugation at 300–6000 rpm for 5–50 min, washed and dried to obtain SH@SiO2 microspheres; (2) Synthesis of DPBA@SiO2: SH@SiO2 (1-50 mg), DPBA (1-20 mg), 2,2-azobis(2-methylpropanediamine) hydrochloride (0.1-5 mg) and triethylamine (1-100 μL) were added to a water / methanol (1-15 mL, v / v, 1:0.5-2) mixture under an inert atmosphere. The reaction solution was kept at 0-95 °C for 1-80 h to obtain DPBA@SiO2. The microspheres were collected by centrifugation at 300-6000 rpm for 5-50 min, washed and dried to obtain DPBA@SiO2 silica microspheres.
5. The application of the flexible double-arm phenylboronic acid-grafted silica ball P1 as described in claim 3 in the process of enriching glycopeptides in proteolytic solutions.
6. The application according to claim 5, characterized in that: (1) Enrichment of glycopeptides was performed using solid-phase extraction. First, 0.1–12 mg of silica sphere P1 packing material was suspended in 0.1–50 μL of acetonitrile. Then, 0.1–50 μL of trypsin peptide solution (0.1–10 mg of lyophilized trypsin peptide powder after membrane protein lysis and desalting dissolved in 0.1–0.85 mL of acetonitrile and 0.9–0.15 mL of 5–50 mM NH4HCO3) was loaded onto the P1 packing material. Subsequently, 0.1–50 μL of 1%–72% acetonitrile / 5–50 mM NH4HCO3 (0.1–0.72 mL of acetonitrile and 0.9–0.28 mL of 50 mM NH4HCO3), 1%–70% acetonitrile / 5–50 mM NH4HCO3, and other solutions were added sequentially. Wash with NH4HCO3 (0.1–0.70 mL of acetonitrile and 0.9–0.30 mL of 50 mM NH4HCO3), and finally elute with 0.1–50 μL of 1%–50% acetonitrile / 0.01%–0.1% formic acid (0.9–0.5 mL of ultrapure water + 0.1–0.5 mL of acetonitrile + 0.1–1 μL of formic acid).
7. A method for preparing a hydrogel P6 or P8 or a cell-imprinted hydrogel P6+ or P8+ containing the flexible double-armed phenylboronic acid as described in claim 1, characterized in that: Preparation of hydrogels P6 or P8 containing flexible double-arm phenylboronic acid: PEGDMA (1-50 mL) and DPBA (1-32 g) are added to a container, with or without acrylamide isothiocyanate fluorescein (0.2-2 g), and 20-100 mL of water is added as a solvent. Subsequently, initiator KPS (0.01-0.8 g) is added, and after mixing for 1-10 hours, the mixture is poured into a sealed container. Initially, the temperature is maintained at 5-30°C for 3-24 hours, then the temperature is increased to 50-180°C, maintained for 6-16 hours, and then decreased to 5-30°C, continuing for 2-10 days (including the initial 9-40 hours). The heating and cooling rates are both 5-10°C / hour. P6 is then removed and immersed in 20-100 mL of water for dialyzing purification for 1-20 days, with the immersion solution water changed daily to obtain hydrogel P6 or hydrogel P8. Preparation of P6+ and P8+ cell-imprinted hydrogels containing flexible double-armed phenylboronic acid: (1)10 2 ~10 6 Place the cells into a cell culture dish with an inner diameter of 1-200 mm and a height of 1-200 mm, add 1-100 mL of cell culture medium, and culture for 8-12 h; remove the culture medium, wash 3-6 times with PBS solution, add 0.1-12 mL of pre-prepared and membrane-passed (0.22 μm) paraformaldehyde solution (mass concentration of 3-6%), fix at 25-37℃ for 1-5 min, remove the fixative, wash 3-6 times with PBS solution, and obtain a cell culture dish with fixed cells; (2) Add PEGDMA (1-50 mL) and DPBA (1-32 g) to a container, with or without adding fluorescein isothiocyanate (0.01-1.5 g), and add 20-100 mL of water as a solvent. Then, add the initiator KPS (0.01-0.8 g), mix well for 1-10 hours, then take out 1-15 mL of the solution and add it to a cell culture dish with fixed cells. Shake at 50-1300 rpm for 0.5-13 hours to allow the functional monomers in the solution to seek target molecules on the cell surface. Then, keep the culture dish at 5-30°C for the first 3-24 hours, then start to raise the temperature to 50-180°C, keep it at 8-16 hours, and then cool it down to 5-30°C. Continue this process for 2-10 days (including the first 11-40 hours), with the heating and cooling rates as follows. The temperature was maintained at 5–10 °C / hour. This yielded P6-cell hydrogels with cell imprints and functional groups. The P6-cell hydrogels were rinsed with water, and water was added from the edge of the cell culture dish to detach the P6-cell hydrogels. The P6-cell hydrogels were then immersed in 20–100 mL of water and dialyzed for 1–20 days to remove unreacted monomers, with the immersion solution water changed daily during this period. Afterward, the gels were removed and immersed in 1–10 mL of trypsin solution. After 1–14 hours, the gels were rinsed 3–6 times with 1–15 mL of phosphate buffer solution and stored in 1–100 mL of PBS solution to prepare either P6+ or P8+ smart responsive molecularly imprinted hydrogels carrying functional monomers and cell micromorphology.
8. A hydrogel P6 or P8 or a cell-imprinted hydrogel P6+ or P8+ containing flexible double-arm phenylboronic acid prepared by the preparation method of claim 7.
9. The use of the hydrogel P6 or P8 or cell-imprinted hydrogel P6+ or P8+ containing flexible double-arm phenylboronic acid as described in claim 8 in the cell capture process.
